UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM10-Q

 

(Mark One)

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 29, 2017

April 3, 2020

OR

 

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period fromto

____________ to___________

Commission File Number0-18655

EXPONENT, INC.

(Exact name of registrant as specified in its charter)

 

DELAWARE

delaware

77-0218904

(State or other jurisdiction of

(I.R.S. Employer Identification No.)

incorporation or organization)

 

149 COMMONWEALTH DRIVE, MENLO PARK, CALIFORNIA94025

149 COMMONWEALTH DRIVE,

MENLO PARK,California

94025

(Address of principal executive office)

(Zip Code)

 

(650) 326-9400

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yesx

No¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yesx

No¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filerx

Accelerated filer¨

Non-accelerated filer¨

Smaller reporting company¨

(Do not check if a smaller
reporting company)

Emerging growth company¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨

[  ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes¨

Nox

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, par value $0.001 per share

EXPO

Nasdaq Global Select Market

 

As of October 27, 2017,May 1, 2020, the latest practicable date, the registrant had 25,810,74951,545,910 shares of common stock $0.001 par value per share, outstanding.

 


 

EXPONENT, INC.

FORM 10-Q

TABLE OF CONTENTS

 

Page

PART I – FINANCIAL INFORMATION

3

Item 1.

Financial Statements (unaudited):

3

Condensed Consolidated Balance Sheets September 29, 2017as of April 3, 2020 and December 30, 2016January 3, 2020

3

Condensed Consolidated Statements of Income for the Three and Nine Months Ended SeptemberApril 3, 2020 and March 29, 2017 and September 30, 20162019

4

Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended SeptemberApril 3, 2020 and March 29, 2017 and September 30, 20162019

5

Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended April 3, 2020 and March 29, 2019

6

Condensed Consolidated Statements of Cash Flows Ninefor the Three Months Ended SeptemberApril 3, 2020 and March 29, 2017 and September 30, 20162019

6

7

Notes to Unaudited Condensed Consolidated Financial Statements

7

8

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

17

20

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

26

27

Item 4.

Controls and Procedures

27

28

PART II – OTHER INFORMATION

29

Item 1.

Legal Proceedings

27

29

Item 1A.

Risk Factors

27

29

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

27

35

Item 3.

Defaults Upon Senior Securities

28

35

Item 4.

Mine Safety Disclosures

28

35

Item 5.

Other Information

28

35

Item 6.

Exhibits

28Exhibits

36

Signatures

29Signatures

37

 

- 2 -


 

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

EXPONENT, INC.

Condensed Consolidated Balance Sheets

September 29, 2017April 3, 2020 and December 30, 2016January 3, 2020

(in thousands, except par value)

(unaudited)

 

 September 29, December 30, 
 2017  2016 

 

April 3,

2020

 

 

January 3,

2020

 

Assets        

 

 

 

 

 

 

 

 

Current assets:        

 

 

 

 

 

 

 

 

Cash and cash equivalents $89,809  $114,967 

 

$

105,594

 

 

$

176,436

 

Short-term investments  75,782   58,755 

 

 

46,449

 

 

 

55,165

 

Accounts receivable, net of allowance for contract losses and doubtful accounts of $3,847 and $3,417 at September 29, 2017 and December 30, 2016, respectively  124,803   87,409 
Prepaid expenses and other assets  10,692   12,913 

Accounts receivable, net of allowance for contract losses and doubtful accounts

of $6,192 and $4,295 at April 3, 2020 and January 3, 2020, respectively

 

 

127,212

 

 

 

120,138

 

Prepaid expenses and other current assets

 

 

14,141

 

 

 

12,305

 

Total current assets  301,086   274,044 

 

 

293,396

 

 

 

364,044

 

        

 

 

 

 

 

 

 

 

Property, equipment and leasehold improvements, net  35,180   36,710 

 

 

60,840

 

 

 

61,587

 

Operating lease right-of-use assets

 

 

21,500

 

 

 

23,003

 

Goodwill  8,607   8,607 

 

 

8,607

 

 

 

8,607

 

Deferred income taxes  42,574   42,166 

 

 

35,151

 

 

 

36,821

 

Deferred compensation plan assets  46,678   41,153 

 

 

63,353

 

 

 

68,400

 

Other assets  1,515   1,064 

 

 

816

 

 

 

949

 

Total assets $435,640  $403,744 

 

$

483,663

 

 

$

563,411

 

        

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity        

 

 

 

 

 

 

 

 

Current liabilities:        

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities $13,813  $10,073 

 

$

14,038

 

 

$

18,583

 

Accrued payroll and employee benefits  59,696   62,539 

 

 

45,729

 

 

 

86,723

 

Deferred revenues  7,776   7,624 

 

 

11,684

 

 

 

12,710

 

Operating lease liabilities

 

 

5,648

 

 

 

5,944

 

Total current liabilities  81,285   80,236 

 

 

77,099

 

 

 

123,960

 

        

 

 

 

 

 

 

 

 

Other liabilities  2,161   2,005 

 

 

2,797

 

 

 

2,669

 

Deferred compensation  50,778   46,503 
Deferred rent  1,340   1,654 

Deferred compensation plan liabilities

 

 

64,026

 

 

 

68,373

 

Operating lease liabilities

 

 

16,244

 

 

 

18,158

 

Total liabilities  135,564   130,398 

 

 

160,166

 

 

 

213,160

 

        
Stockholders’ equity:        

 

 

 

 

 

 

 

 

Common stock, $0.001 par value; 80,000 shares authorized; 32,853 shares issued at September 29, 2017 and December 30, 2016  33   33 

Common stock, $0.001 par value; 120,000 shares authorized; 65,707 shares

issued at April 3, 2020 and January 3, 2020

 

 

66

 

 

 

66

 

Additional paid-in capital  208,583   194,632 

 

 

257,389

 

 

 

244,935

 

Accumulated other comprehensive income (loss)        

 

 

 

 

 

 

 

 

Investment securities, available-for-sale  (129)  (146)

 

 

470

 

 

 

302

 

Foreign currency translation adjustments  (1,934)  (2,980)

 

 

(3,735

)

 

 

(2,062

)

  (2,063)  (3,126)

 

 

(3,265

)

 

 

(1,760

)

Retained earnings  313,277   291,243 

 

 

395,646

 

 

 

384,668

 

Treasury stock, at cost; 7,043 and 7,256 shares held at September 29, 2017 and December 30, 2016, respectively  (219,754)  (209,436)

Treasury stock, at cost; 14,161 and 13,951 shares held at April 3, 2020 and January 3, 2020, respectively

 

 

(326,339

)

 

 

(277,658

)

Total stockholders’ equity  300,076   273,346 

 

 

323,497

 

 

 

350,251

 

Total liabilities and stockholders’ equity $435,640  $403,744 

 

$

483,663

 

 

$

563,411

 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.

- 3 -


EXPONENT, INC.

Condensed Consolidated Statements of Income

For the Three Months Ended April 3, 2020 and March 29, 2019

(in thousands, except per share data)

(unaudited)

 

 

Three Months Ended

 

 

 

April 3,

2020

 

 

March 29,

2019

 

Revenues:

 

 

 

 

 

 

 

 

Revenues before reimbursements

 

$

99,720

 

 

$

93,401

 

Reimbursements

 

 

6,233

 

 

 

5,630

 

Revenues

 

 

105,953

 

 

 

99,031

 

Operating expenses:

 

 

 

 

 

 

 

 

Compensation and related expenses

 

 

49,985

 

 

 

65,093

 

Other operating expenses

 

 

8,216

 

 

 

8,008

 

Reimbursable expenses

 

 

6,233

 

 

 

5,630

 

General and administrative expenses

 

 

5,531

 

 

 

4,546

 

Total operating expenses

 

 

69,965

 

 

 

83,277

 

Operating income

 

 

35,988

 

 

 

15,754

 

Other income, net:

 

 

 

 

 

 

 

 

Interest income, net

 

 

875

 

 

 

1,055

 

Miscellaneous income (loss), net

 

 

(12,808

)

 

 

6,513

 

Total other income (loss), net

 

 

(11,933

)

 

 

7,568

 

Income before income taxes

 

 

24,055

 

 

 

23,322

 

Income taxes

 

 

(2,227

)

 

 

610

 

Net income

 

$

26,282

 

 

$

22,712

 

Net income per share:

 

 

 

 

 

 

 

 

Basic

 

$

0.50

 

 

$

0.43

 

Diluted

 

$

0.49

 

 

$

0.42

 

Shares used in per share computations:

 

 

 

 

 

 

 

 

Basic

 

 

52,575

 

 

 

52,536

 

Diluted

 

 

53,657

 

 

 

53,814

 

Cash dividends declared per common share

 

$

0.19

 

 

$

0.16

 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements

- 4 -


EXPONENT, INC.

Condensed Consolidated Statements of Comprehensive Income

For the Three Months Ended April 3, 2020 and March 29, 2019

(in thousands)

(unaudited)

 

 

Three Months Ended

 

 

 

April 3,

2020

 

 

March 29,

2019

 

Net income

 

$

26,282

 

 

$

22,712

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

Foreign currency translation

   adjustments, net of tax

 

 

(1,673

)

 

 

117

 

Unrealized gains on available-for-sale

   investment securities arising during

   the period, net of tax

 

 

168

 

 

 

154

 

Comprehensive income

 

$

24,777

 

 

$

22,983

 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements

- 5 -


EXPONENT, INC.

Condensed Consolidated Statements of Stockholders’ Equity

(in thousands)

(unaudited)

 

 

Three Months Ended April 3, 2020

 

 

 

Common Stock

 

 

Additional

paid-in

 

 

Accumulated

other

comprehensive

 

 

Retained

 

 

Treasury Stock

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

capital

 

 

income (loss)

 

 

earnings

 

 

Shares

 

 

Amount

 

 

Total

 

Balance at January 3, 2020

 

 

65,707

 

 

$

66

 

 

$

244,935

 

 

$

(1,760

)

 

$

384,668

 

 

 

13,951

 

 

$

(277,658

)

 

$

350,251

 

Employee stock purchase plan

 

 

-

 

 

 

-

 

 

 

400

 

 

 

-

 

 

 

-

 

 

 

(7

)

 

 

73

 

 

 

473

 

Exercise of stock options

 

 

 

 

 

 

 

 

 

 

64

 

 

 

 

 

 

 

 

 

 

 

(60

)

 

 

608

 

 

 

672

 

Amortization of unrecognized stock-based compensation

 

 

-

 

 

 

-

 

 

 

4,095

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,095

 

Purchase of treasury shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

636

 

 

 

(40,049

)

 

 

(40,049

)

Foreign currency translation adjustments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,673

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,673

)

Grant of restricted stock units to settle accrued bonus

 

 

-

 

 

 

-

 

 

 

8,645

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

8,645

 

Settlement of restricted stock units

 

 

-

 

 

 

-

 

 

 

(1,261

)

 

 

-

 

 

 

(4,538

)

 

 

(359

)

 

 

(9,313

)

 

 

(15,112

)

Unrealized gain on investments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

168

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

168

 

Dividends and dividend equivalent rights

 

 

-

 

 

 

-

 

 

 

511

 

 

 

-

 

 

 

(10,766

)

 

 

-

 

 

 

-

 

 

 

(10,255

)

Net income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

26,282

 

 

 

-

 

 

 

-

 

 

 

26,282

 

Balance at April 3, 2020

 

 

65,707

 

 

$

66

 

 

$

257,389

 

 

$

(3,265

)

 

$

395,646

 

 

 

14,161

 

 

$

(326,339

)

 

$

323,497

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 29,  2019

 

 

 

Common Stock

 

 

Additional

paid-in

 

 

Accumulated

other

comprehensive

 

 

Retained

 

 

Treasury Stock

 

 

 

 

 

(In thousands)

 

Shares

 

 

Amount

 

 

capital

 

 

income (loss)

 

 

earnings

 

 

Shares

 

 

Amount

 

 

Total

 

Balance at December 28, 2018

 

 

65,707

 

 

$

66

 

 

$

227,283

 

 

$

(2,853

)

 

$

342,024

 

 

 

14,208

 

 

$

(252,611

)

 

$

313,909

 

Employee stock purchase plan

 

 

-

 

 

 

-

 

 

 

302

 

 

 

-

 

 

 

-

 

 

 

(7

)

 

 

70

 

 

 

372

 

Amortization of unrecognized stock-based compensation

 

 

-

 

 

 

-

 

 

 

3,663

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,663

 

Foreign currency translation adjustments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

117

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

117

 

Grant of restricted stock units to settle accrued bonus

 

 

-

 

 

 

-

 

 

 

7,947

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

7,947

 

Settlement of restricted stock units

 

 

-

 

 

 

-

 

 

 

(860

)

 

 

-

 

 

 

(5,146

)

 

 

(395

)

 

 

(5,188

)

 

 

(11,194

)

Unrealized gain on investments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

154

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

154

 

Dividends and dividend equivalent rights

 

 

-

 

 

 

-

 

 

 

581

 

 

 

-

 

 

 

(9,084

)

 

 

-

 

 

 

-

 

 

 

(8,503

)

Net income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

22,712

 

 

 

-

 

 

 

-

 

 

 

22,712

 

Balance at March 29, 2019

 

 

65,707

 

 

$

66

 

 

$

238,916

 

 

$

(2,582

)

 

$

350,506

 

 

 

13,806

 

 

$

(257,729

)

 

$

329,177

 

 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.

 

- 3 -

 

EXPONENT, INC.

 

Condensed Consolidated Statements of Income

For the Three and Nine Months Ended September 29, 2017 and September 30, 2016

(in thousands, except per share data)

(unaudited)

  Three Months Ended  Nine Months Ended 
  

September 29,

2017

  

September 30,

2016

  

September 29,

2017

  

September 30,

2016

 
             
Revenues:                
Revenues before reimbursements $82,359  $74,160  $246,946  $226,444 
Reimbursements  5,196   3,452   12,571   11,619 
                 
Revenues  87,555   77,612   259,517   238,063 
                 
Operating expenses:                
Compensation and related expenses  51,493   47,797   157,447   146,854 
Other operating expenses  7,500   7,020   21,966   21,221 
Reimbursable expenses  5,196   3,452   12,571   11,619 
General and administrative expenses  4,061   3,748   13,277   11,407 
                 
Total operating expenses  68,250   62,017   205,261   191,101 
                 
Operating income  19,305   15,595   54,256   46,962 
                 
Other income, net:                
Interest income, net  372   179   872   489 
Miscellaneous income, net  2,353   2,146   6,660   4,880 
Total other income, net  2,725   2,325   7,532   5,369 
                 
Income before income taxes  22,030   17,920   61,788   52,331 
                 
Income taxes  7,387   6,631   16,778   15,239 
                 
Net income $14,643  $11,289  $45,010  $37,092 
                 
Net income per share:                
Basic $0.56  $0.43  $1.71  $1.40 
Diluted $0.54  $0.42  $1.67  $1.36 
                 
Shares used in per share computations:                
Basic  26,370   26,545   26,362   26,563 
Diluted  26,963   27,185   26,976   27,234 
                 
Cash dividends declared per common share $0.21  $0.18  $0.63  $0.54 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements

- 46 -


EXPONENT, INC.

Condensed Consolidated Statements of Comprehensive Income

For the Three and Nine Months Ended September 29, 2017 and September 30, 2016

(in thousands)

(unaudited)

  Three Months Ended  Nine Months Ended 
  September 29,
2017
  September 30,
2016
  September 29,
2017
  September 30,
2016
 
             
Net income $14,643  $11,289  $45,010  $37,092 
Other comprehensive income (loss):                
Foreign currency translation adjustments, net of tax  456   (186)  1,046   (696)
Unrealized gains (losses) on available-for- sale investment securities arising during the period, net of tax  13   (19)  17   65 
                 
Comprehensive income $15,112  $11,084  $46,073  $36,461 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements

- 5 -

EXPONENT, INC.

Condensed Consolidated Statements of Cash Flows

For the NineThree Months Ended SeptemberApril 3, 2020 and March 29, 2017 and September 30, 20162019

(in thousands)

(unaudited)

 

 Nine Months Ended 

 

Three Months Ended

 

 

September 29,

2017

 

September 30,

2016

 

 

April 3,

2020

 

 

March 29,

2019

 

Cash flows from operating activities:        

 

 

 

 

 

 

 

 

Net income $45,010  $37,092 

 

$

26,282

 

 

$

22,712

 

Adjustments to reconcile net income to net cash provided by operating activities:        

Adjustments to reconcile net income to net cash used in

operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization of property, equipment and leasehold improvements  4,762   4,509 

 

 

1,786

 

 

 

1,590

 

Amortization of premiums and accretion of discounts on short-term investments  -   7 

 

 

(60

)

 

 

(132

)

Deferred rent  (314)  (330)
Provision for contract losses and doubtful accounts  1,657   1,688 

 

 

2,383

 

 

 

788

 

Stock-based compensation  12,728   10,659 

 

 

6,138

 

 

 

5,731

 

Deferred income tax provision  (421)  (1,284)

 

 

1,614

 

 

 

161

 

Changes in operating assets and liabilities:        

 

 

 

 

 

 

 

 

Accounts receivable  (39,051)  (7,403)

 

 

(9,457

)

 

 

(13,838

)

Prepaid expenses and other assets  1,049   (342)

Prepaid expenses and other current assets

 

 

(12,561

)

 

 

(10,431

)

Change in operating leases

 

 

(707

)

 

 

(425

)

Accounts payable and accrued liabilities  3,950   (1,059)

 

 

(4,110

)

 

 

(333

)

Accrued payroll and employee benefits  (2,558)  (4,091)

 

 

(24,117

)

 

 

(16,477

)

Deferred revenues  152   (2,212)

 

 

(1,026

)

 

 

(1,599

)

Net cash provided by operating activities  26,964   37,234 
        

Net cash used in operating activities

 

 

(13,835

)

 

 

(12,253

)

Cash flows from investing activities:        

 

 

 

 

 

 

 

 

Capital expenditures  (3,354)  (13,063)

 

 

(1,293

)

 

 

(5,670

)

Purchase of short-term investments  (20,997)  (36,000)

 

 

-

 

 

 

(23,848

)

Maturity of short-term investments  4,000   29,950 

 

 

9,000

 

 

 

13,000

 

Net cash used in investing activities  (20,351)  (19,113)
        

Net cash provided by (used in) investing activities

 

 

7,707

 

 

 

(16,518

)

Cash flows from financing activities:        

 

 

 

 

 

 

 

 

Payroll taxes for restricted stock units  (9,520)  (7,685)

 

 

(15,112

)

 

 

(11,194

)

Repurchase of common stock  (8,431)  (24,456)

 

 

(40,049

)

 

 

-

 

Exercise of share-based payment awards  1,733   1,499 

Exercise of stock-based payment awards

 

 

1,145

 

 

 

372

 

Dividends and dividend equivalents rights  (16,419)  (14,174)

 

 

(10,308

)

 

 

(8,593

)

Net cash used in financing activities  (32,637)  (44,816)

 

 

(64,324

)

 

 

(19,415

)

        
Effect of foreign currency exchange rates on cash and cash equivalents  866   (631)

 

 

(390

)

 

 

207

 

        
Net decrease in cash and cash equivalents  (25,158)  (27,326)

 

 

(70,842

)

 

 

(47,979

)

Cash and cash equivalents at beginning of period  114,967   125,751 

 

 

176,436

 

 

 

127,059

 

Cash and cash equivalents at end of period $89,809  $98,425 

 

$

105,594

 

 

$

79,080

 

 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.

- 67 -


 

EXPONENT, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1:  Basis of Presentation

Exponent, Inc. (referred to as the “Company” or “Exponent”) is an engineering and scientific consulting firm that provides solutions to complex problems. The Company operates on a 52-53 week fiscal year ending on the Friday closest to the last day of December.

The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to Form 10-Q and Article 10 of Regulation S-X promulgated by the U.S. Securities and Exchange Commission. Accordingly, they do not contain all the information and notes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments which are necessary for the fair presentation of the condensed consolidated financial statements have been included and all such adjustments are of a normal and recurring nature. The operating results for the three and nine months ended September 29, 2017April 3, 2020 are not necessarily representative of the results of future quarterly or annual periods. The following information should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2016,January 3, 2020, which was filed with the U.S. Securities and Exchange Commission on February 24, 2017.

28, 2020.

The unaudited condensed consolidated financial statements include the accounts of Exponent, Inc. and its subsidiaries, which are all wholly owned. All intercompany accounts and transactions have been eliminated in consolidation.

Dividend. The Company declared and paid cash dividends per common share during the periods presented as follows:

  Fiscal Year 2017 
  Dividends  Amount 
  Per Share  (in thousands) 
First Quarter $0.21  $5,374 
Second Quarter  0.21   5,424 
Third Quarter  0.21   5,424 
Total $0.63  $16,222 

  Fiscal Year 2016 
  Dividends  Amount 
  Per Share  (in thousands) 
First Quarter $0.18  $4,628 
Second Quarter  0.18   4,675 
Third Quarter  0.18   4,659 
Fourth Quarter  0.18   4,607 
Total $0.72  $18,569 

On October 18, 2017, the Company’s Board of Directors announced a cash dividend of $0.21 per share of the Company’s common stock, payable December 22, 2017, to stockholders of record as of December 1, 2017. The Company expects to continue paying quarterly dividends in the future, subject to declaration by the Company’s Board of Directors.

Use of Estimates.The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant itemsItems subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates. The Company’s estimate of its allowance for contract losses and doubtful accounts takes into consideration the macroeconomic effect of global events such as the COVID-19 pandemic which may impact the ability of its customers to pay.

- 7 -

RecentRecently Adopted Accounting Pronouncements Not Yet Effective. On May 28, 2014,Pronouncements. In June 2016, the Financial Accounting Standards Board (“FASB”) issuedestablished Topic 326, Measurement of Credit Losses on Financial Instruments, by issuing Accounting Standard Update (“ASU”) No. 2014-09,Revenue from Contracts2016-13, Financial Instruments – Credit Losses, which replaces the incurred loss methodology with Customers, which requires an entityexpected loss methodology that is referred to recognizeas the amountcurrent expected credit loss (“CECL”) methodology. The measurement of revenuethe expected credit losses under the CECL methodology is applicable to which it expectsfinancial assets measured at amortized cost where there is a contractual right to be entitled for the transfer of promised goods or services to customers.receive cash, including, accounts receivables, loan receivables and held-to-maturity debt securities. The Company adopted ASU will replace most existing revenue recognition guidanceNo. 2016-13 in U.S. generally accepted accounting principles (“GAAP”) when it becomes effective. The new standard is effective for the Company on the first dayquarter of fiscal 2018 (December 30, 2017). The two permitted transition methods under2020 and the new standard are the full retrospective method, in which case the standard would be applied to each prior reporting period presented, or the modified retrospective method, in which case the cumulative effect of applying the standard would be recognized at the date of initial application.

The impact of adopting the new standard isadoption was not expectedmaterial to be material because the analysis of the Company’s contracts under the new revenue recognition standard supports the recognition of revenue over time, which is consistent with the Company’s current revenue recognition model.condensed consolidated financial statements.

Note 2:  Revenue Recognition

Substantially all of the Company’s engagements are performed under time and materialmaterials or fixed-price arrangements. For time and materials contracts, the Company anticipates utilizingutilizes the practical expedient under the ASUAccounting Standards Codification 606 – Revenue from Contracts with Customers, which states that if an entity has a right to consideration from a customer in an amount that corresponds directly with the value of the entity’s performance completed to date (for example, a service contract in which an entity bills a fixed amount for each hour orof service provided), then the entity may recognize revenue in the amount to which the entity has a right to invoice. Application

- 8 -


The following table discloses the percent of the practical expedient toCompany’s revenue generated from time and material contracts is consistent with the Company’s current revenue recognition policy.materials contracts:  

 

 

Three Months Ended

 

 

 

April 3,

2020

 

 

March 29,

2019

 

Engineering & other scientific

 

 

66

%

 

 

66

%

Environmental and health

 

 

19

%

 

 

18

%

Total time and materials revenues

 

 

85

%

 

 

84

%

 

 

 

 

 

 

 

 

 

 

For fixed pricefixed-price contracts, the Company will recognizerecognizes revenue over time under the ASU because of the continuous transfer of control to the customer. The customer typically controls the work in process as evidenced either by contractual termination clauses or by the Company’s rights to payment for work performed to date to deliver services that do not have an alternative use to the Company. Input methods are an acceptable method of measuring progress towards completing under the ASU. ThisRevenue for fixed-price contracts is consistent with the Company’s current policy of measuring progress towards completionrecognized based on the relationship of incurred labor hours at standard rates to itsthe Company’s estimate of the total labor hours at standard rates it expects to incur over the term of the contract. The Company believes this methodology achieves a reliable measure of the revenue from the consulting services it provides to its customers under fixed-price contracts given the nature of the consulting services the Company provides.

The following table discloses the percent of the Company’s revenue generated from fixed price contracts.

The Company anticipates adopting the standard using the modified retrospective method. The Company is currently evaluating the required disclosures under the new standard and developing appropriate changes to its process, systems and controls.

On February 25, 2016, the FASB issued ASU No. 2016-02,Leases, which requires lessees to recognize most leases on their balance sheet.  The new standard will be effective for the Company on the first day of fiscal 2019 (December 29, 2018).  Early adoption is permitted.  The standard requires use of the modified retrospective transition method, with elective relief, which requires application of the guidance for all periods presented.  The Company is evaluating the effect that ASU No. 2016-02 will have on its consolidated financial statements and related disclosures.  The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting. The standard will require the Company to record a right of use asset and a lease liability that will materially gross up its balance sheet.contracts:  

 

 

 

Three Months Ended

 

 

 

April 3,

2020

 

 

March 29,

2019

 

Engineering & other scientific

 

 

14

%

 

 

15

%

Environmental and health

 

 

1

%

 

 

1

%

Total fixed price revenues

 

 

15

%

 

 

16

%

 

 

 

 

 

 

 

 

 

Deferred revenues represent amounts billed to clients in advance of services provided. During the first quarter of 2020, $4,791,000 of revenues were recognized that were included in the deferred revenue balance at January 3, 2020. During the first quarter of 2019, $3,411,000 of revenues were recognized that were included in the deferred revenue balance at December 28, 2018.

Reimbursements, including those related to travel and other out-of-pocket expenses, and other similar third- party costs such as the cost of materials and certain subcontracts, are included in revenues, and an equivalent amount of reimbursable expenses are included in operating expenses. Any mark-up on reimbursable expenses is included in revenues before reimbursements. The Company reports revenues net of subcontractor fees for certain subcontracts where the Company has determined that it is acting as an agent because its performance obligation is to arrange for the provision of goods or services by another party. The total amount of subcontractor fees not included in revenues because the Company was acting as an agent were $3,781,000 during the first quarter of 2020. The total amount of subcontractor fees not included in revenues because the Company was acting as an agent were $4,242,000 during the first quarter of 2019.

- 89 -


 

Note 2:3: Fair Value Measurements

The Company measures certain financial assets and liabilities at fair value on a recurring basis, including available-for-sale fixed income securities, trading fixed income and equity securities held in its deferred compensation plan and the liability associated with its deferred compensation plan. There were no transfers between fair value measurement levels during the three and nine months ended SeptemberApril 3, 2020 and March 29, 2017 and September 30, 2016.2019. Any transfers between fair value measurement levels would be recorded on the actual date of the event or change in circumstances that caused the transfer. The fair value of these certain financial assets and liabilities was determined using the following inputs at September 29, 2017:April 3, 2020 (in thousands):

 

  Fair Value Measurements at Reporting Date Using 
(In thousands) Total  

Quoted Prices in
Active Markets for
Identical Assets

(Level 1)

  

 

Significant Other
Observable Inputs

(Level 2)

  

Significant
Unobservable
Inputs

(Level 3)

 
             
Assets                
Money market  securities(1) $5,265  $5,265  $-  $- 
                 
Fixed income available-for-sale securities(2)  75,782   -   75,782   - 
                 
Fixed income trading securities held in deferred compensation plan(3)  14,210  ��14,210   -   - 
                 
Equity trading securities held in deferred compensation plan(3)  36,569   36,569   -   - 
Total $131,826  $56,044  $75,782  $- 
                 
Liabilities                
Deferred compensation plan(4)  56,479   56,479   -   - 
Total $56,479  $56,479  $-  $- 

 

 

Fair Value Measurements at Reporting Date Using

 

 

 

Total

 

 

Quoted

Prices in

Active

Markets

for

Identical

Assets

(Level 1)

 

 

Significant

Other

Observable

Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market securities (1)

 

$

4,758

 

 

$

4,758

 

 

$

-

 

 

$

-

 

Fixed income available-for-sale securities (2)

 

 

46,449

 

 

 

-

 

 

 

46,449

 

 

 

-

 

Fixed income trading securities held in deferred

   compensation plan (3)

 

 

29,905

 

 

 

29,905

 

 

 

-

 

 

 

-

 

Equity trading securities held in deferred compensation

   plan (3)

 

 

38,937

 

 

 

38,937

 

 

 

-

 

 

 

-

 

Total

 

$

120,049

 

 

$

73,600

 

 

$

46,449

 

 

$

-

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred compensation plan (4)

 

 

69,865

 

 

 

69,865

 

 

 

-

 

 

 

-

 

Total

 

$

69,865

 

 

$

69,865

 

 

$

-

 

 

$

-

 

(1)

Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet.

(2)

Included in short-term investments on the Company’s unaudited condensed consolidated balance sheet.

(3)

Included in prepaid expenses and other current assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet.

(4)

Included in accrued payroll and employee benefits and deferred compensation plan liabilities on the Company’s unaudited condensed consolidated balance sheet.

- 910 -


 

The fair value of these certain financial assets and liabilities was determined using the following inputs at December 30, 2016:January 3, 2020 (in thousands):

 

  Fair Value Measurements at Reporting Date Using 
(In thousands) Total  

Quoted Prices in
Active Markets for
Identical Assets

(Level 1)

  

 

Significant Other
Observable Inputs

(Level 2)

  

Significant
Unobservable
Inputs

(Level 3)

 
             
Assets                
Money market  securities(1) $21,918  $21,918  $-  $- 
                 
Fixed income available-  for-sale securities(2)  58,755   -   58,755   - 
                 
Fixed income trading securities held in deferred compensation plan(3)  11,872   11,872   -   - 
                 
Equity trading securities held in deferred compensation plan(3)  36,395   36,395   -   - 
Total $128,940  $70,185  $58,755  $- 
                 
Liabilities                
Deferred compensation plan(4)  53,617   53,617   -   - 
Total $53,617  $53,617  $-  $- 

 

 

Fair Value Measurements at Reporting Date Using

 

 

 

Total

 

 

Quoted

Prices in

Active

Markets

for

Identical

Assets

(Level 1)

 

 

Significant

Other

Observable

Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market securities (1)

 

$

41,211

 

 

$

41,211

 

 

$

-

 

 

$

-

 

Fixed income available for sale securities (2)

 

 

55,165

 

 

 

-

 

 

 

55,165

 

 

 

-

 

Fixed income trading securities held in deferred

   compensation plan (3)

 

 

22,010

 

 

 

22,010

 

 

 

-

 

 

 

-

 

Equity trading securities held in deferred compensation

   plan (3)

 

 

53,924

 

 

 

53,924

 

 

 

-

 

 

 

-

 

Total

 

$

172,310

 

 

$

117,145

 

 

$

55,165

 

 

$

-

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred compensation plan (4)

 

 

76,357

 

 

 

76,357

 

 

 

-

 

 

 

-

 

Total

 

$

76,357

 

 

$

76,357

 

 

$

-

 

 

$

-

 

(1)

Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet.

(2)

Included in short-term investments on the Company’s unaudited condensed consolidated balance sheet.

(3)

Included in prepaid expenses and other current assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet.

(4)

Included in accrued payroll and employee benefits and deferred compensation plan liabilities on the Company’s unaudited condensed consolidated balance sheet.

Fixed income available-for-sale securities as of September 29, 2017April 3, 2020 and December 30, 2016January 3, 2020 represent obligations of the United States agencies.Treasury. Fixed income and equity trading securities represent mutual funds held in the Company’s deferred compensation plan. See Note 67 for additional information about the Company’s deferred compensation plan.

- 10 -

Cash, cash equivalents and short-term investments consisted of the following as of September 29, 2017:April 3, 2020 (in thousands):

 

 Amortized Unrealized Unrealized Estimated 

 

 

 

 

 

Gross

 

 

Gross

 

 

 

 

 

(In thousands) Cost  Gains  Losses  Fair Value 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Estimated

 

         

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

Classified as current assets:                

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash $84,544  $-  $-  $84,544 

 

$

100,836

 

 

$

-

 

 

$

-

 

 

$

100,836

 

                
Cash equivalents:                

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market securities  5,265   -   -   5,265 

 

 

4,758

 

 

 

-

 

 

 

-

 

 

 

4,758

 

Total cash equivalents  5,265   -   -   5,265 

 

 

4,758

 

 

 

-

 

 

 

-

 

 

 

4,758

 

Total cash and cash equivalents  89,809   -   -   89,809 

 

 

105,594

 

 

 

-

 

 

 

-

 

 

 

105,594

 

                
Short-term investments:                

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. agency securities  75,997   -   (215)  75,782 

U.S. Treasury and agency securities

 

 

45,901

 

 

 

548

 

 

 

 

 

 

 

46,449

 

Total short-term investments  75,997   -   (215)  75,782 

 

 

45,901

 

 

 

548

 

 

 

-

 

 

 

46,449

 

                
Total cash, cash equivalents and short-term investments $165,806  $-  $(215) $165,591 

 

$

151,495

 

 

$

548

 

 

$

-

 

 

$

152,043

 

 

- 11 -


Cash, cash equivalents and short-term investments consisted of the following as of December 30, 2016:January 3, 2020 (in thousands):

 

  Amortized  Unrealized  Unrealized  Estimated 
(In thousands) Cost  Gains  Losses  Fair Value 
             
Classified as current assets:                
Cash $93,049  $-  $-  $93,049 
                 
Cash equivalents:                
Money market securities  21,918   -   -   21,918 
Total cash equivalents  21,918   -   -   21,918 
Total cash and cash equivalents  114,967   -   -   114,967 
                 
Short-term investments:                
U.S. agency securities  59,000   -   (245)  58,755 
Total short-term investments  59,000   -   (245)  58,755 
                 
Total cash, cash equivalents and short-term investments $173,967  $-  $(245) $173,722 

- 11 -

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Estimated

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

Classified as current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

135,225

 

 

$

-

 

 

$

-

 

 

$

135,225

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market securities

 

 

41,211

 

 

 

-

 

 

 

-

 

 

 

41,211

 

Total cash equivalents

 

 

41,211

 

 

 

-

 

 

 

-

 

 

 

41,211

 

Total cash and cash equivalents

 

 

176,436

 

 

 

-

 

 

 

-

 

 

 

176,436

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury and agency securities

 

 

54,841

 

 

 

324

 

 

 

-

 

 

 

55,165

 

Total short-term investments

 

 

54,841

 

 

 

324

 

 

 

-

 

 

 

55,165

 

Total cash, cash equivalents and short-term investments

 

$

231,277

 

 

$

324

 

 

$

-

 

 

$

231,601

 

 

The following table summarizesAt April 3, 2020 the cost and estimated fair valuestated effective maturities of all short-term fixed income securities classified as short-term investments based on stated effective maturities as of September 29, 2017:were due within one year.

  Amortized  Estimated 
(In thousands) Cost  Fair Value 
       
Due within one year $40,000  $39,919 
Due between one and two years  35,997   35,863 
Total $75,997  $75,782 

 

At September 29, 2017April 3, 2020 and December 30, 2016,January 3, 2020, the Company did not have any assets or liabilities valued using significant unobservable inputs.

The following financial instruments are not measured at fair value on the Company's unaudited condensed consolidated balance sheet at September 29, 2017April 3, 2020 and December 30, 2016,January 3, 2020 but require disclosure of their fair values: accounts receivable, other assets and accounts payable. The estimated fair value of such instruments at September 29, 2017April 3, 2020 and December 30, 2016January 3, 2020 approximates their carrying value as reported on the Company’s unaudited condensed consolidated balance sheet.

There were no other-than-temporary impairments or credit losses related to available-for-sale securities during the three and nine months ended SeptemberApril 3, 2020 and March 29, 2017 and September 30, 2016.2019.

Note 3:4:  Net Income Per Share

Basic per share amounts are computed using the weighted-average number of common shares outstanding during the period. Diluted per share amounts are calculated using the weighted-average number of common shares outstanding during the period and, when dilutive, the weighted-average number of potential common shares from the issuance of common stock to satisfy outstanding restricted stock units and the exercise of outstanding options to purchase common stock using the treasury stock method.

The following schedule reconciles the shares used to calculate basic and diluted net income per share:

 

  Three Months Ended  Nine Months Ended 
(In thousands) 

September 29,

2017

  

September 30,

2016

  

September 29,

2017

  

September 30,

2016

 
             
Shares used in basic per share computation  26,370   26,545   26,362   26,563 
Effect of dilutive common stock options  outstanding  147   115   139   121 
Effect of dilutive restricted stock units outstanding  446   525   475   550 
                 
Shares used in diluted per share computation  26,963   27,185   26,976   27,234 

 

 

Three Months Ended

 

(In thousands)

 

April 3,

2020

 

 

March 29,

2019

 

Shares used in basic per share computation

 

 

52,575

 

 

 

52,536

 

Effect of dilutive common stock options

   outstanding

 

 

379

 

 

 

455

 

Effect of dilutive restricted stock units

   outstanding

 

 

703

 

 

 

823

 

Shares used in diluted per share

   computation

 

 

53,657

 

 

 

53,814

 

 

There- 12 -


Common stock options to purchase 22,418 shares were no options excluded from the diluted per share calculationscalculation for the three and nine months ended SeptemberApril 3, 2020 due to their anti-dilutive effect.Common stock options to purchase 24,176 shares were excluded from the diluted per share calculation for the three months ended March 29, 2017 and September 30, 2016.2019 due to their anti-dilutive effect.

Note 4:5:  Stock-Based Compensation

Restricted Stock Units

Restricted stock unit grants are designed to attract and retain employees, and to better align employee interests with those of the Company’s stockholders. For a select group of employees, up to 40% of their annual bonus is settled with fully vested restricted stock unit awards. Under these fully vested restricted stock unit awards, the holder of each award has the right to receive one share of the Company’s common stock for each fully vested restricted stock unit four years from the date of grant. Each individual who receives a fully vested restricted stock unit award is also granted a matching number of unvested restricted stock unit awards. Unvested restricted stock unit awards are also granted for select new hires and promotions. These unvested restricted stock unit awards generally cliff vest four years from the date of grant, at which time the holder of each award will have the right to receive one share of the Company’s common stock for each restricted stock unit award provided the holder of each award has met certain employment conditions. In the case of retirement at 59½ years or older, all unvested restricted stock unit awards will continue to vest, provided that the holder of each award does all consulting work through the Company and does not become an employee for a past or present client, beneficial party or competitor of the Company.

- 12 -

The value of these restricted stock unit awards is determined based on the market price of the Company’s common stock on the date of grant. The value of fully vested restricted stock unit awards issued is recorded as a reduction to accrued bonuses. The portion of bonus expense that the Company expects to settle with fully vested restricted stock unit awards is recorded as stock-based compensation during the period the bonus is earned. The Company recorded stock-based compensation expense associated with accrued bonus awards of $2,155,000$2,043,000 and $1,548,000$2,068,000 during the three months ended SeptemberApril 3, 2020 and March 29, 2017 and September 30, 2016, respectively. For the nine months ended September 29, 2017 and September 30, 2016, the Company recorded stock-based compensation expense associated with accrued bonus awards of $6,284,000 and $4,716,000,2019, respectively. The value of the unvested restricted stock unit awards granted is recognized on a straight-line basis over the shorter of the four-year vesting period or the period between the grant date and the date the award recipient turns 59½. If the award recipient is 59½ years or older on the date of grant, the value of the entire award is expensed upon grant. The Company recorded stock-based compensation expense associated with the unvested restricted stock unit awards of $3,927,000 and $3,530,000 during the three months ended April 3, 2020 and March 29, 2019, respectively.

Stock Options

Stock options are granted for terms of ten years and generally vest 25% per year over a four-year period from the grant date. Unvested stock option awards will continue to vest in the case of retirement at 59½ years or older, provided that the holder of each award does all consulting work through the Company and does not become an employee for a past or present client, beneficial party or competitor of the Company. The value of the unvested stock option awards granted is recognized on a straight-line basis over the shorter of the four-year vesting period or the period between the grant date and the date the award recipient turns 59½. If the award recipient is 59½ years or older on the date of grant, the value of the entire award is expensed upon grant. The Company recorded stock-based compensation expense associated with the unvested restricted stock unit awardsoption grants of $1,294,000$168,000 and $1,115,000$133,000 during the three months ended SeptemberApril 3, 2020 and March 29, 2017 and September 30, 2016,2019, respectively. The Company recorded stock-based compensation expense associated with the unvested restricted stock unit awards of $5,788,000 and $5,447,000 during the nine months ended September 29, 2017 and September 30, 2016, respectively.

Stock Options

Stock options are granted for terms of ten years and generally vest 25% per year over a four-year period from the grant date. Unvested stock option awards will continue to vest in the case of retirement at 59½ years or older, provided that the holder of each award does all consulting work through the Company and does not become an employee for a past or present client, beneficial party or competitor of the Company. The Company grants options at exercise prices equal to the fair value of the Company’s common stock on the date of grant. The Company recorded stock-based compensation expense associated with stock option grants of $92,000 and $67,000 during the three months ended September 29, 2017 and September 30, 2016, respectively. The Company recorded stock-based compensation expense associated with stock option grants of $656,000 and $496,000 during the nine months ended September 29, 2017 and September 30, 2016, respectively.

The Company uses the Black-Scholes option-pricing model to determine the fair value of options granted. The determination of the fair value of stock option awards on the date of grant using an option-pricing model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables. These variables include expected stock price volatility over the term of the award, actual and projected employee stock option exercise behaviors, the risk-free interest rate and expected dividends.

- 13 -


 

The Company used historical exercise, forfeiture, and post-vesting forfeiture and expiration data to estimate the expected term of options granted. The historical volatility of the Company’s common stock over a period of time equal to the expected term of the options granted was used to estimate expected volatility. The risk-free interest rate used in the option-pricing model was based on United States Treasury zero-coupon issues with remaining terms similar to the expected term of the options. The dividend yield assumption considers the expectation of continued declaration of dividends, offset by option holders’ dividend equivalent rights.

The Company accounts for forfeitures of stock-based awards when they occur. All stock-based payment awards are recognized on a straight-line basis over the requisite service periods of the awards.

- 13 -

Note 5:6:  Treasury Stock

On October 21, 2015,19, 2016, the Company’s Board of Directors authorized $35,000,000 for the repurchase of shares of the Company’s common stock. On October 19, 2016,January 31, 2019, the Company’s Board of Directors authorized an additional $35,000,000$75,000,000 for the repurchase of shares of the Company’s common stock.

These repurchase programs have no expiration date.

The Company repurchased 139,182636,000 shares of its common stock for $8,431,000$40,049,000 during the ninethree months ended September 29, 2017.April 3, 2020. The Company repurchased 491,312did 0t repurchase any shares of its common stock for $24,456,000 during the ninethree months ended September 30, 2016.March 29, 2019. As of September 29, 2017April 3, 2020, the Company had remaining authorization under its stock repurchase plans of $48,876,000 to repurchase shares of common stock.$30,455,000.

Net losses related to the re-issuance of treasury stock to settle restricted stock unit and stock option awards of $5,667,000 and $5,791,000 were recorded as a reduction to retained earnings during the nine months ended September 29, 2017 and September 30, 2016, respectively. There were no net losses related to the re-issuance of treasury stock during the three months ended September 29, 2017 and September 30, 2016.

Note 6:7:  Deferred Compensation Plans

The Company maintains nonqualified deferred compensation plans for the benefit of a select group of highly compensated employees. Under these plans, participants may elect to defer up to 100% of their compensation. Company assets that are earmarked to pay benefits under the plans are held in a rabbi trust and are subject to the claims of the Company’s creditors. As of September 29, 2017April 3, 2020, and December 30, 2016,January 3, 2020, the invested amounts under the plans totaled $50,779,000$68,842,000 and $48,267,000,$75,934,000 respectively and are recorded in pre-paidprepaid expenses and other current assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet. These assets are classified as trading securities and are recorded at fair value with changes recorded as adjustments to miscellaneous income (loss), net.

  

As of September 29, 2017April 3, 2020, and December 30, 2016,January 3, 2020, vested amounts due under the plans totaled $56,479,000$69,865,000 and $53,617,000,$76,357,000 respectively and are recorded within accrued payroll and employee benefits and deferred compensation plan liabilities on the Company’s unaudited condensed consolidated balance sheet. Changes in the liability are recorded as adjustments to compensation expense. During the three months ended September 29, 2017 and September 30, 2016,April 3, 2020, the Company recognized a reduction to compensation expense of $1,699,000 and $1,458,000, respectively,$(14,622,000). During the three months ended March 29, 2019 the Company recognized additional compensation expense of $5,869,000 as a result of changes in the market value of the trust assets with the same amount being recorded as income in miscellaneous income (loss), net.  During the nine months ended September 29, 2017 and September 30, 2016, the Company recognized compensation expense of $4,617,000 and $2,823,000, respectively, as a result of changes in the market value of the trust assets with the same amount being recorded as income in miscellaneous income, net.

Note 7:8: Supplemental Cash Flow Information

The following is supplemental disclosure of cash flow information:

 

 Nine Months Ended 

 

Three Months Ended

 

(In thousands) 

September 29,

2017

 

September 30,

2016

 

 

April 3,

2020

 

 

March 29,

2019

 

     
Cash paid during period:        

 

 

 

 

 

 

 

 

Income taxes $17,208  $13,375 

 

$

1,231

 

 

$

440

 

Non-cash investing and financing activities:        

 

 

 

 

 

 

 

 

Unrealized gain on short-term investments $17  $65 

 

$

168

 

 

$

154

 

Vested stock unit awards issued to settle accrued bonuses $6,910  $6,334 

 

$

8,645

 

 

$

7,947

 

Accrual for capital expenditures $162  $739 

 

$

229

 

 

$

1,903

 

Right-of-use asset obtained in exchange for operating lease obligations

 

$

-

 

 

$

25,653

 

 

- 14 -


 

Note 8:9: Accounts Receivable, Net

At September 29, 2017April 3, 2020 and December 30, 2016,January 3, 2020, accounts receivable, net, was comprised of the following:

 

 September 29, December 30, 

 

April 3,

 

 

January 3,

 

(In thousands) 2017  2016 

 

2020

 

 

2020

 

     
Billed accounts receivable $90,263  $60,510 

 

$

92,953

 

 

$

85,579

 

Unbilled accounts receivable  38,387   30,316 

 

 

40,451

 

 

 

38,854

 

Allowance for contract losses and doubtful accounts  (3,847)  (3,417)

 

 

(6,192

)

 

 

(4,295

)

Total accounts receivable, net $124,803  $87,409 

 

$

127,212

 

 

$

120,138

 

The Company maintains allowances for estimated losses over the remaining contractual life of its receivables resulting from the inability of customers to meet their financial obligations or for disputes that affect the Company’s ability to fully collect amounts due. In circumstances where the Company is aware of a specific customer’s inability to meet its financial obligations or aware of a dispute with a specific customer, a specific allowance is recorded to reduce the net recognized receivable to the amount the Company reasonably believes will be collected. For all other customers the Company recognizes allowances for doubtful accounts based upon historical write-offs, customer concentration, customer creditworthiness, current economic conditions, aging of amounts due and future expectations.

A reconciliation of the beginning and ending amount of the allowance for contract losses and doubtful accounts is as follows (in thousands):

Balance at January 3, 2020

 

$

4,295

 

Provision for contract losses and doubtful accounts

 

 

2,383

 

Write-offs

 

 

(486

)

Balance at April 3, 2020

 

$

6,192

 

The provision for contract losses and doubtful accounts for the first quarter of 2020 includes approximately $1,500,000 as a result of the economic uncertainty associated with the COVID-19 pandemic. Recoveries of accounts receivable previously written-off were not material during the first quarter of 2020.

- 15 -


On January 29, 2019, PG&E Corp. (“PG&E”) filed for bankruptcy under chapter 11 of the U.S. bankruptcy code. As of April 3, 2020, the Company’s total pre-bankruptcy outstanding accounts receivable from PG&E was $3,000,000. The Company currently expects to collect substantially all of the pre-bankruptcy accounts receivable from PG&E. However, due to the risks and uncertainties inherent in the bankruptcy process, the amount ultimately collected could differ from the Company’s current expectation. The Company continues to do work for PG&E post-bankruptcy filing and expects to be paid for this work in the ordinary course of business. Under the United States Bankruptcy code, PG&E is required to pay all post-bankruptcy expenses in the normal course of business. If they do not do so, the Company is eligible to have the post-bankruptcy obligation categorized as an administrative expense entitled to priority over most pre-bankruptcy creditors.

Note 9:10:  Segment Reporting

The Company has two reportable operating segments based on two primary areas of service. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices primarily in engineering. The Environmental and Health segment provides services in the areaareas of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and the impact on both human health and the environment.

Our Chief Executive Officer, the chief operating decision maker, reviews revenues and operating income for each of our reportable segments but does not review total assets in evaluating segment performance and capital allocation.

Segment information for the three and nine months ended SeptemberApril 3, 2020 and March 29, 2017 and September 30, 20162019 follows:

Revenues

 

Revenues

  Three Months Ended  Nine Months Ended 
(In thousands) 

September 29,

2017

  

September 30,

2016

  

September 29,

2017

  

September 30,

2016

 
             
Engineering and Other Scientific $70,670  $61,237  $207,148  $187,026 
Environmental and Health  16,885   16,375   52,369   51,037 
                 
Total revenues $87,555  $77,612  $259,517  $238,063 

Operating Income

  Three Months Ended  Nine Months Ended 
(In thousands) 

September 29,

2017

  

September 30,

2016

  

September 29,

2017

  

September 30,

2016

 
             
Engineering and Other Scientific $23,645  $19,933  $70,279  $60,632 
Environmental and Health  5,450   4,758   16,753   13,981 
                 
Total segment operating income  29,095   24,691   87,032   74,613 
                 
Corporate operating expense  (9,790)  (9,096)  (32,776)  (27,651)
                 
Total operating income $19,305  $15,595  $54,256  $46,962 

- 15 -

 

 

Three Months Ended

 

(In thousands)

 

April 3,

2020

 

 

March 29,

2019

 

Engineering and Other Scientific

 

$

84,887

 

 

$

80,254

 

Environmental and Health

 

 

21,066

 

 

 

18,777

 

Total revenues

 

$

105,953

 

 

$

99,031

 

 

Capital ExpendituresOperating Income

 

 Three Months Ended  Nine Months Ended 

 

Three Months Ended

 

(In thousands)

 

September 29,

2017

 

September 30,

2016

 

September 29,

2017

 

September 30,

2016

 

 

April 3,

2020

 

 

March 29,

2019

 

         
Engineering and Other Scientific $662  $902  $2,464  $3,365 

 

$

26,641

 

 

$

25,974

 

Environmental and Health  64   33   170   94 

 

 

7,253

 

 

 

6,196

 

                
Total segment capital expenditures  726   935   2,634   3,459 
                
Corporate capital expenditures  102   8,746   720   9,604 
                
Total capital expenditures $828  $9,681  $3,354  $13,063 

Total segment operating income

 

 

33,894

 

 

 

32,170

 

Corporate operating expense

 

 

2,094

 

 

 

(16,416

)

Total operating income

 

$

35,988

 

 

$

15,754

 

 

- 16 -


Capital Expenditures

 

 

Three Months Ended

 

(In thousands)

 

April 3,

2020

 

 

March 29,

2019

 

Engineering and Other Scientific

 

$

566

 

 

$

1,778

 

Environmental and Health

 

 

62

 

 

 

43

 

Total segment capital expenditures

 

 

628

 

 

 

1,821

 

Corporate capital expenditures

 

 

411

 

 

 

4,520

 

Total capital expenditures

 

$

1,039

 

 

$

6,341

 

Depreciation and Amortization

 

 Three Months Ended  Nine Months Ended 

 

Three Months Ended

 

(In thousands)

 

September 29,

2017

 

September 30,

2016

 

September 29,

2017

 

September 30,

2016

 

 

April 3,

2020

 

 

March 29,

2019

 

         
Engineering and Other Scientific $1,103  $1,136  $3,381  $3,273 

 

$

1,137

 

 

$

1,121

 

Environmental and Health  47   45   132   133 

 

 

47

 

 

 

45

 

                
Total segment depreciation and amortization  1,150   1,181   3,513   3,406 

 

 

1,184

 

 

 

1,166

 

                
Corporate depreciation and amortization  417   401   1,249   1,103 

 

 

602

 

 

 

424

 

                
Total depreciation and amortization $1,567  $1,582  $4,762  $4,509 

 

$

1,786

 

 

$

1,590

 

 

One client comprised 17% of the Company’s revenues during the three months ended September 29, 2017. The same client comprised 14% of the Company’s revenues during the nine months ended September 29, 2017. No otherNaN single client comprised more than 10% of the Company’s revenues during the three and nine months ended SeptemberApril 3, 2020 and March 29, 2017. No single client comprised more than 10% of the Company’s revenues during the three and nine months ended September 30, 2016. The same client comprised 29% of the Company’s accounts receivable at September 29, 2017. No other2019. NaN single client comprised more than 10% of the Company’s accounts receivable at September 29, 2017. No single client comprised more than 10%April 3, 2020 and January 3, 2020.

Note 11: Leases

The Company determines if an arrangement is a lease at the inception of the arrangement. Operating leases are included in operating lease ROU assets, current operating lease liabilities, and long-term operating lease liabilities in the Company’s accounts receivablecondensed consolidated balance sheet. The Company does not have any finance leases as of April 3, 2020.

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at December 30, 2016.commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate, based on the information available at commencement date, in determining the present value of lease payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The amortization of operating lease ROU assets and the change in operating lease liabilities is disclosed as a single line item in the condensed consolidated statement of cash flows.

The Company leases office, laboratory, and storage space in 13 states and the District of Columbia, as well as in Germany, China, Hong Kong, Singapore, Switzerland, and the United Kingdom. Leases for these office, laboratory, and storage facilities have terms generally ranging between one and ten years. Some of these leases include options to extend or terminate the lease, none of which are currently included in the lease term as the Company has determined that exercise of these options is not reasonably certain.

- 17 -


The Company has a Test and Engineering Center on 147 acres of land in Phoenix, Arizona. The Company leases this land from the state of Arizona under a 30-year lease agreement that expires in January of 2028 and has options to renew for 2 fifteen-year periods. As of April 3, 2020, the Company has determined that exercise of the renewal options is not reasonably certain and thus the extension is not included in the lease term.

The Company’s equipment leases are included in the ROU asset and liability balances but are not material.

The Company leases excess space in its Silicon Valley and Natick facilities. Rental income of $991,000 and $741,000 was included in other income for the three months ended April 3, 2020 and March 29, 2019, respectively.

The components of lease expense included in other operating expenses on the condensed consolidated statement of income were as follows:

 

 

Three Months Ended

 

 

Three Months Ended

 

(In thousands)

 

April 3,

2020

 

 

March 29,

2019

 

Operating lease cost

 

$

1,778

 

 

$

1,870

 

Variable lease cost

 

 

290

 

 

 

380

 

Short-term lease cost

 

 

125

 

 

 

95

 

Supplemental cash flow information related to operating leases was as follows:

 

 

Three Months Ended

 

 

Three Months Ended

 

(In thousands)

 

April 3,

2020

 

 

March 29,

2019

 

Cash paid for amounts included in the measurement of

   operating lease liabilities

 

$

2,434

 

 

$

2,534

 

Supplemental balance sheet information related to operating leases was as follows:

 

April 3, 2020

 

 

March 29, 2019

 

Weighted Average Remaining Lease Term

5.0 years

 

 

5.6 years

 

Weighted Average Discount Rate

4.4%

 

 

4.5%

 

Maturities of operating lease liabilities as of April 3, 2020:

(In thousands)

 

Operating Leases

 

2020

 

$

4,503

 

2021

 

 

5,993

 

2022

 

 

4,773

 

2023

 

 

3,187

 

2024

 

 

2,176

 

2025

 

 

1,491

 

2026

 

 

1,507

 

2027

 

 

1,466

 

Total lease payments

 

$

25,096

 

Less imputed interest

 

 

(3,204

)

Total lease liability

 

$

21,892

 

- 18 -


 

Note 10:12:  Contingencies

The Company is a party to various legal actions from time to time and may be contingently liable in connection with claims and contracts arising in the normal course of business, the outcome of which the Company believes, after consultation with legal counsel, will not have a material adverse effect on its financial condition, results of operations or liquidity. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results. All legal costs associated with litigation are expensed as incurred.

Note 13: Subsequent Events

On April 30, 2020, the Company’s Board of Directors announced a cash dividend of $0.19 per share of the Company’s common stock, payable June 26, 2020, to stockholders of record as of June 12, 2019.

- 1619 -


Item 2.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included herein and with our audited consolidated financial statements and notes thereto for the fiscal year ended December 30, 2016,January 3, 2020, which are contained in our fiscal 20162019 Annual Report on Form 10-K, which was filed with the U.S. Securities and Exchange Commission on February 24, 201728, 2020 (our “2016“2019 Annual Report”).

Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the COVID-19 pandemic (including factors relating to measures implemented by governmental authorities or by us to promote the safety of our employees, vendors and clients; other direct and indirect impacts on our business and the businesses of our clients, vendors and other partners; impacts which may, among other things, adversely affect our clients’ ability to utilize our services at the levels they have previously; disruptions of access to our facilities or those of our clients or third parties; and increased and potentially significant economic uncertainty and volatility, including credit and collectability risks and potential disruptions of capital and credit markets), the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our 2016 Annualthis Quarterly Report under the heading “Risk Factors” and elsewhere in thethis report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. Due to such uncertainties and risks, you are warned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. The Company does not intend to release publicly any updates or revisions to any such forward-looking statements.

Business Overview

Exponent, Inc., is an engineering and scientific consulting firm that provides solutions to complex problems. Our multidisciplinary team of scientists, engineers and business consultants brings together more than 90 different technical disciplines to solve complicated issues facing industry and business today. Our services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property and impending litigation.

CRITICAL ACCOUNTING ESTIMATES

In preparing our unaudited condensed consolidated financial statements, we make assumptions, judgments and estimates that canThere have abeen no significant impact on our revenue, operating income and net income, as well as on the value of certain assets and liabilities on our consolidated balance sheet. We base our assumptions, judgments and estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions or conditions. On a regular basis we evaluate our assumptions, judgments and estimates and make changes accordingly. We believe that the assumptions, judgments and estimates involved in the accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts have the greatest potential impact on our consolidated financial statements, so we consider these to be our critical accounting policies. Historically, our assumptions, judgments and estimates relativeduring the three months ended April 3, 2020, as compared to ourthe critical accounting policies have not differed materially from actual results. Policies covering revenue recognitionestimates disclosed in Management’s Discussion and estimating the allowance for contract lossesAnalysis of Financial Condition and doubtful accounts are describedResults of Operations included in our 20162019 Annual Report under “Critical Accounting Estimates” and Note 1 (Summary of Significant Accounting Policies) of the Notes to Consolidated Financial Statements.Report.

- 1720 -


 

RESULTS OF CONSOLIDATED OPERATIONS

Executive Summary

Revenues for the thirdfirst quarter of 20172020 increased 13%7% to $87,555,000$105,953,000 as compared to $77,612,000$99,031,000 during the same period last year. Revenues before reimbursements for the thirdfirst quarter of 20172020 increased 11%7% to $82,359,000$99,720,000 as compared to $74,160,000$93,401,000 during the same period last year. We experienced strong demand forBusiness restrictions related to the COVID-19 impacted our consulting services from a diverse setAsian operations starting in late January, and certain areas of clients for both proactiveour European and reactive projects. We continue to see demand for our proactive servicesUnited States operations in the areassecond half of design and regulatory consulting, specifically related to consumer electronics, and our reactive services in international construction disputes, consumer product recalls and product liability claims.

March.

During the thirdfirst quarter of 20172020, we had strong growth in our biomechanics, biomedical engineering, chemical regulation &and food safety, construction consulting, electrical engineering & computer science, human factors, mechanical engineering, and polymer science & materials chemistryvehicle engineering practices. During the quarter we continued to work on a large human factors assessmentMultinational companies across industries engaged our interdisciplinary teams of world-class consultants for a client in the consumer products industry. The level of activity for this project increased during the quarter, driving increases in both revenuescientific expertise and profitability. This project represented approximately 8% of our revenues before reimbursements in the third quarter of 2017 and approximately 6% of our revenues before reimbursements for the first nine months of 2017. During the quarter we also continued our international construction disputes work with current mining, gas terminal and power plant projects. We also experienced growth from lithium-ion battery consulting for clients in the consumer products, transportation, medical device, and utility industries. Our interdisciplinary team of chemists, electrical engineers, material scientists and mechanical engineers has guided clients with respect to the performance, reliability, and safety of new products, as well as with respect to recalls and litigation matters involving existing products with lithium-ion batteries.

risk assessments.

Net income increased 30%16% to $14,643,000$26,282,000 during the thirdfirst quarter of 20172020 as compared to $11,289,000$22,712,000 during the same period last year. Diluted earnings per share increased to $0.54$0.49 per share as compared to $0.42 in the same period last year. WeThe increases in net income and diluted earnings per share were ableprimarily due to improve profitabilitythe 7% increase in revenues before reimbursements and margins by effectively managing headcount over the past year to aligna decrease in our resources with demand and benefited from a large human factors assessment for a clienteffective tax rate. The decrease in the consumer products industry, which resultedeffective tax rate was due to an increase in improved utilizationthe excess tax benefit associated with stock-based awards. The excess tax benefit associated with stock-based awards increased to $8,772,000 during the first quarter of 2020 as compared to $5,670,000 during the same period last year.

COVID-19 Update 

We are addressing the challenges associated with the COVID-19 pandemic with the same seriousness, intellectual rigor, and increased leveragefact-based analysis that we have employed for over 50 years. We are focused on three things: ensuring the health and safety of our cost structure.people, demonstrating leadership by continuing to solve our clients’ most pressing problems, and delivering value to shareholders. Our employees have been working from home since the initiation of shelter in place orders, with the exception of laboratory and inspection activities for essential businesses. Our business development process has evolved to adapt to a remote working environment and new engagements continue to be initiated by inbound client communication based on our reputation and long-standing relationships. 

We continue to see strong demand for utility integrity management services, as clients focus on power reliability while their customers are asked to stay at home. Preparation for fire season is an additional market driver in this sector. Our chemical regulation and food safety services represent an ongoing area of strength, as clients must continue to comply with complex regulations as they distribute products around the world.

We have seen slowing of a portion of our litigation support projects due to courthouse closures and associated legal delays. However, courts are beginning to utilize technology to hold virtual hearings and trials. Travel restrictions are delaying work that requires inspection of a site or a product that cannot be shipped, but as restrictions begin to ease, Exponent’s broad geographic footprint will be a competitive advantage as it puts our consultants within driving distance of many locations. The pandemic has also temporarily paused our user studies, but we are actively adapting the study designs and implementing processes and technologies so that we can restart them as quickly as possible, while ensuring the health and safety of our participants and employees.  

Our scientific experts are more committed than ever to delivering actionable thought leadership, especially where it can help to manage and mitigate risk associated with the COVID-19 pandemic. Our interdisciplinary teams are addressing questions about occupational health and safety, development and regulation of new medical devices, disinfectants and personal protective equipment, global supply chain optimization, insurance claims and litigation.

- 21 -


Business Outlook 

Exponent’s fundamentals are sound and our market drivers are strong, despite uncertainties surrounding how and over what timeframe each region will relax business restrictions and physical distancing requirements. Clients continue to retain Exponent for our scientific expertise and sound advice, but the rate of new project engagements has slowed. With our talented workforce intact, we are well-positioned to execute on paused work and the anticipated acceleration of new work as business restrictions are eased. The COVID-19 pandemic has caused revenues for the first three weeks of the second quarter to decline approximately 15% to 20% as compared to the same period last year. As business restrictions continue, there could be further reduction to our revenues in the short term.

We remain focused on selectively adding top talent and developing the skills necessary to expand our market position and providing clients with in-depth scientific research and analysis to determine what happened and how to prevent failures or exposures in the future. We also remain focused on capitalizing on emerging growth areas, managing other operating expenses, generating cash from operations, maintaining a strong balance sheet and undertaking activities such as share repurchases and dividends to enhance shareholder value.

Overview of the Three Months Ended September 29, 2017

April 3, 2020

During the thirdfirst quarter of 2017,2020 billable hours increased 12%6% to 310,000348,000 as compared to 278,000329,000 during the same period last year. Our utilization increaseddecreased to 76%71% during the thirdfirst quarter of 20172020 as compared to 70%72% during the same period last year. Technical full-time equivalent employees increased 3%6% to 787938 during the thirdfirst quarter of 20172020 as compared to 761883 during the same period last year. We continue to selectively hire key talent to expand our capabilities.

- 18 -

Three Months Ended September 29, 2017April 3, 2020 compared to Three Months Ended September 30, 2016March 29, 2019

Revenues

 

Revenues     
 Three Months Ended    

 

Three Months Ended

 

 

 

 

 

(in thousands, except percentages)

 

September 29,

2017

 

September 30,

2016

 

Percent

Change

 

 

April 3,

2020

 

 

March 29,

2019

 

 

Percent

Change

 

       
Engineering and Other Scientific $70,670  $61,237   15.4%

 

$

84,887

 

 

$

80,254

 

 

 

5.8

%

Percentage of total revenues  80.7%  78.9%    

 

 

80.1

%

 

 

81.0

%

 

 

 

 

Environmental and Health  16,885   16,375   3.1%

 

 

21,066

 

 

 

18,777

 

 

 

12.2

%

Percentage of total revenues  19.3%  21.1%    

 

 

19.9

%

 

 

19.0

%

 

 

 

 

            
Total revenues $87,555  $77,612   12.8%

 

$

105,953

 

 

$

99,031

 

 

 

7.0

%

 

The increase in revenues for our Engineering and Other Scientific segment was due to an increase in billable hours.hours and an increase in billing rates. During the thirdfirst quarter of 2017,2020, billable hours for this segment increased by 13%5% to 242,000271,000 as compared to 214,000258,000 during the same period last year. Utilization for this segment increaseddecreased to 78%71% during the thirdfirst quarter of 20172020 as compared to 73% during the same period last year. The increase in billable hours and utilization was due to strong growth in our biomechanics, biomedical engineering, mechanical engineering, and vehicle engineering practices. Multinational companies across industries engaged Exponent’s interdisciplinary teams of world-class consultants for scientific expertise and risk assessments. During the first quarter of 2020, this segment benefited from our proactive design consulting services, specificallya large project for an electric utility client evaluating the integrity of their infrastructure and helping to mitigate safety risks related to ongoing projects with clientswildfires. The decrease in utilization was due to business restrictions related to COVID-19 that impacted our Asian operations in late January and certain areas of our European and United States operations during the consumer products industry. During the quarter we continued work on a large human factors assessment for a client in the consumer products industry. In addition to the ongoing large human factors assessment project, we realized increased demand for similar services from other clients. We have developed a unique offeringsecond half of highly qualified scientists and facilities to advise clients as they navigate the increasing complexity of interactions between their products and users. We also experienced growth from lithium-ion battery consulting for clients in the consumer products, transportation, medical device, and utility industries. Our interdisciplinary team of chemists, electrical engineers, material scientists and mechanical engineers has guided clients with respect to the performance, reliability, and safety of new products, as well as with respect to recalls and litigation matters involving existing products with lithium-ion batteries.March. Technical full-time equivalent employees in this segment increased 5%8% to 594731 during the thirdfirst quarter of 20172020 as compared to 566679 for the same period last year due to our continuing recruiting and retention efforts.

- 22 -


 

The increase in revenues for our Environmental and Health segment was due to an increase in billable hours.hours and an increase in billing rates. During the thirdfirst quarter of 2017,2020, billable hours for this segment increased by 6%9% to 68,00077,000 as compared to 64,00071,000 during the same period last year. Utilization in this segment increased to 68%72% during the thirdfirst quarter of 20172020 as compared to 63%67% during the same period last year. The increase in billable hours and utilization was due to growth in our chemical regulation and food safety practice, where we continued to assist clients with global regulatory issues. This segment’s contribution toour scientists evaluated the large ongoingeffects of chemicals and new products on human factors assessment also contributed tohealth and the increase in billable hours and utilization. These increases were partially offset by depressed demand from the oil and gas and industrial chemical industries.environment. Technical full-time equivalent employees in this segment decreased byincreased 1% to 193207 during the thirdfirst quarter of 20172020 as compared to 195204 during the same period last year. The decrease in technical full-time equivalent employees was due to our efforts to align resources with anticipated demand.

Compensation and Related Expenses

 

Compensation and Related Expenses     
 Three Months Ended    

 

Three Months Ended

 

 

 

 

 

(in thousands, except percentages)

 

September 29,

2017

 

September 30,

2016

 

Percent

Change

 

 

April 3,

2020

 

 

March 29,

2019

 

 

Percent

Change

 

       
Compensation and related expenses $51,493  $47,797   7.7%

 

$

49,985

 

 

$

65,093

 

 

 

-23.2

%

Percentage of total revenues  58.8%  61.6%    

 

 

47.2

%

 

 

65.7

%

 

 

 

 

 

The increasedecrease in compensation and related expenses during the thirdfirst quarter of 20172020 was due to a change in the value of assets associated with our deferred compensation plan partially offset by an increase in bonuspayroll expense and an increase in payroll expense. Bonusfringe benefits. During the first quarter of 2020, deferred compensation expense decreased by $20,491,000 with a corresponding decrease to other income, net, as compared to the same period last year, due to the change in value of assets associated with our deferred compensation plan. This decrease consisted of a decrease in the value of plan assets of $14,622,000 during the first quarter of 2020 as compared to an increase in the value of plan assets of $5,869,000 during the same period last year. Payroll expense increased by $2,392,000$3,452,000 during the thirdfirst quarter of 2017 due to a corresponding increase to income before income taxes, before bonus expense, and before stock-based compensation. Payroll expense increased $854,0002020 due to the increase in technical full-time equivalent employees.employees and the impact of our annual salary adjustments. Fringe benefits increased by $1,323,000 during the first quarter of 2020 due to the increase in technical full-time equivalent employees and the impact of our annual salary adjustments. We expect our compensation expense, excluding the change in value of deferred compensation plan assets, to increase as we selectively add new talent and adjust compensation to market conditions.

Other Operating Expenses

 

- 19 -

 

 

Three Months Ended

 

 

 

 

 

(in thousands, except percentages)

 

April 3,

2020

 

 

March 29,

2019

 

 

Percent

Change

 

Other operating expenses

 

$

8,216

 

 

$

8,008

 

 

 

2.6

%

Percentage of total revenues

 

 

7.8

%

 

 

8.1

%

 

 

 

 

Other Operating Expenses      
  Three Months Ended    

 

(in thousands, except percentages)

 

September 29,

2017

  

September 30,

2016

  

Percent

Change

 
          
Other operating expenses $7,500  $7,020   6.8%
Percentage of total revenues  8.6%  9.0%    

 

Other operating expenses include facilities-related costs, technical materials, computer-related expenses and depreciation and amortization of property, equipment and leasehold improvements. The increase in other operating expenses during the thirdfirst quarter of 20172020 was primarily due to an increase in occupancydepreciation and amortization expense of $265,000 and$196,000, an increase in computeroccupancy expenses of $119,000, and several other individually insignificant increases partially offset by a decrease in technical materials of $189,000. The increases in depreciation and amortization expense of $137,000 associated withand occupancy expense were due to our increase in technical full-time equivalent employees and investments in our corporate infrastructure. The decrease in technical materials was due to the impact of COVID-19 related restrictions on our operations. We expect other operating expenses to grow as we selectively add new talent and make investments in our corporate infrastructure.

- 23 -

Reimbursable Expenses      
  Three Months Ended    

 

(in thousands, except percentages)

 

September 29,

2017

  

September 30,

2016

  

Percent

Change

 
          
Reimbursable expenses $5,196  $3,452   50.5%
Percentage of total revenues  5.9%  4.4%    

 

The increase in reimbursable expenses was primarily due to an increase in travel related costs associated with our large human factors assessment project. Reimbursable Expenses

 

 

Three Months Ended

 

 

 

 

 

(in thousands, except percentages)

 

April 3,

2020

 

 

March 29,

2019

 

 

Percent

Change

 

Reimbursable expenses

 

$

6,233

 

 

$

5,630

 

 

 

10.7

%

Percentage of total revenues

 

 

5.9

%

 

 

5.7

%

 

 

 

 

The amount of reimbursable expenses will vary from quarter to quarter depending on the nature of our projects.

General and Administrative Expenses

General and Administrative Expenses      
  Three Months Ended    
(in thousands, except percentages) 

September 29,

2017

  

September 30,

2016

  

Percent

Change

 
          
General and administrative expenses $4,061  $3,748   8.4%
Percentage of total revenues  4.6%  4.8%    

 

 

Three Months Ended

 

 

 

 

 

(in thousands, except percentages)

 

April 3,

2020

 

 

March 29,

2019

 

 

Percent

Change

 

General and administrative expenses

 

$

5,531

 

 

$

4,546

 

 

 

21.7

%

Percentage of total revenues

 

 

5.2

%

 

 

4.6

%

 

 

 

 

 

The increase in general and administrative expenses during the thirdfirst quarter of 20172020 was primarily due to an increase in bad debt expense of $91,000, an increase$1,365,000 partially offset by a decrease in travel and meals of $90,000, and an$440,000. The increase in legal expensesbad debt was due to additional reserves we booked to our allowance for doubtful accounts as a result of $87,000.the economic uncertainty associated with the COVID-19 pandemic. The decrease in travel and meals was due to the travel restrictions put in place due to the COVID-19 pandemic. We expect general and administrative expenses to increase as we selectively add new talent and expand our business development initiatives, and pursue staff development initiatives.

Other Income, Net

Other Income, Net      
  Three Months Ended    

 

(in thousands, except percentages)

 

September 29,

2017

  

September 30,

2016

  

Percent

Change

 
          
Other income, net $2,725  $2,325   17.2%
Percentage of total revenues  3.1%  3.0%    

 

 

Three Months Ended

 

 

 

 

 

(in thousands, except percentages)

 

April 3,

2020

 

 

March 29,

2019

 

 

Percent

Change

 

Other income, net

 

$

(11,933

)

 

$

7,568

 

 

 

-257.7

%

Percentage of total revenues

 

 

-11.3

%

 

 

7.6

%

 

 

 

 

 

Other income, net, consists primarily of changes in the value of assets associated with our deferred compensation plan, interest income earned on available cash, cash equivalents and short-term investments, and rental income from leasing space in our Silicon Valley facility. The increasedecrease in other income, net, was primarily due to an increase in interest income of $193,000 and a change in the value of assets associated with our deferred compensation plan. Theplan partially offset by an increase in interest income was due to higher interest rates for our cash equivalents and short-term investments.the realized gain on foreign exchange of $910,000. During the thirdfirst quarter of 2017,2020, other income, net, increased $241,000decreased by $20,491,000 with a corresponding increasedecrease to deferred compensation expense, as compared to the same period last year, due to a change in the value of assets associated with our deferred compensation plan. This increasedecrease consisted of an increasea decrease in the value of the plan assets of $1,699,000$14,622,000 during the thirdfirst quarter of 20172020 as compared to an increase in the value of the plan assets of $1,458,000$5,869,000 during the same period last year. The increase in the realized gain on foreign exchange was due to an increase in the value of monetary assets denominated in non-functional currencies.

- 24 -


Income Taxes

 

- 20 -

 

 

Three Months Ended

 

 

 

 

 

(in thousands, except percentages)

 

April 3,

2020

 

 

March 29,

2019

 

 

Percent

Change

 

Income taxes

 

$

(2,227

)

 

$

610

 

 

 

-465.1

%

Percentage of total revenues

 

 

-2.1

%

 

 

0.6

%

 

 

 

 

Effective tax rate

 

 

-9.3

%

 

 

2.6

%

 

 

 

 

Income Taxes      
  Three Months Ended    
(in thousands, except percentages) 

September 29,

2017

  

September 30,

2016

  

Percent

Change

 
          
Income taxes $7,387  $6,631   11.4%
Percentage of total revenues  8.4%  8.5%    
Effective tax rate  33.5%  37.0%    

 

The increase in income tax expense was due to a corresponding increase in pre-tax income. The decrease in ourthe effective tax rate was due to an increase in the excess tax benefit associated with share-based awards and a decrease in our unrecognized tax benefit.stock-based awards. The excess tax benefit associated with share-basedstock-based awards increased to $464,000$8,772,000 during the thirdfirst quarter of 20172020 as compared to $39,000$5,670,000 during the same period last year. DuringExcluding the thirdimpact of the excess tax benefit, the effective tax rate would have been 27.2% during the first quarter of 2017 we released $437,000 of our unrecognized tax benefit due to the completion of two tax audits.

Nine Months Ended September 29, 2017 compared to Nine Months Ended September 30, 2016

Revenues      
  Nine Months Ended    

(in thousands, except percentages)

 

September 29,

2017

  

September 30,

2016

  

Percent

Change

 
          
Engineering and Other Scientific $207,148  $187,026   10.8%
Percentage of total revenues  79.8%  78.6%    
Environmental and Health  52,369   51,037   2.6%
Percentage of total revenues  20.2%  21.4%    
             
Total revenues $259,517  $238,063   9.0%

The increase in revenues for our Engineering and Other Scientific segment was due to an increase in billable hours. During the first nine months of 2017, billable hours for this segment increased by 9% to 709,0002020 as compared to 649,000 during the same period last year. Utilization for this segment increased to 78% during the first nine months of 2017 as compared to 74% during the same period last year. The increase in billable hours and utilization was due to strong growth from our proactive design and regulatory consulting services, specifically related to ongoing projects with clients in the consumer products industry. During the first nine months of 2017 we performed a large human factors assessment for a client in the consumer products industry. We continued to expand our broad base of international construction dispute work with ongoing mining, gas terminal and power plant projects leveraging our integrated team of experts to deliver solutions to complex capital projects. Technical full-time equivalent employees in this segment increased 4% to 584 during the first nine months of 2017 as compared to 563 for the same period last year due to our continuing recruiting and retention efforts.

The increase in revenues for our Environmental and Health segment was due to an increase in billable hours. During the first nine months of 2017, billable hours for this segment increased by 4% to 207,000 as compared to 199,000 during the same period last year. Utilization in this segment increased to 69% during the first nine months of 2017 as compared to 63% during the same period last year. The increase in billable hours and utilization was due to growth in our chemical regulation and food safety practice where we continued to assist clients with global regulatory issues. This segment’s contribution to the large ongoing human factors assessment also contributed to the increase in billable hours and utilization. These increases were partially offset by depressed demand from the oil and gas and industrial chemical industries. Technical full-time equivalent employees in this segment decreased by 5% to 192 during the first nine months of 2017 as compared to 203 during the same period last year. The increase in utilization and the decrease in technical full-time equivalent employees were due to our efforts to align resources with anticipated demand.

- 21 -

Compensation and Related Expenses      
  Nine Months Ended    

 

(in thousands, except percentages)

 

September 29,

2017

  

September 30,

2016

  

Percent

Change

 
          
Compensation and related expenses $157,447  $146,854   7.2%
Percentage of total revenues  60.7%  61.7%    

The increase in compensation and related expenses during the first nine months of 2017 was due to an increase in bonus expense, an increase in payroll expense and fringe benefits, an increase in stock-based compensation, and a change in the value of assets associated with our deferred compensation plan. Bonus expense increased by $5,467,000 during the first nine months of 2017 due to a corresponding increase to income before income taxes, before bonus expense, and before stock-based compensation. Payroll expense increased $2,453,000 and fringe benefits increased $291,000 due to the increase in technical full-time equivalent employees and our annual salary increases. Stock-based compensation increased by $460,000 due primarily to an increase in the amortization of restricted stock unit grants. During the first nine months of 2017, deferred compensation expense increased $1,794,000 with a corresponding increase to other income, net, as compared to the same period last year due to a change in value of assets associated with our deferred compensation plan. This increase consisted of an increase in the value of plan assets of $4,617,000 during the first nine months of 2017 as compared to an increase in the value of plan assets of $2,823,00026.9% during the same period last year.

Other Operating Expenses      
  Nine Months Ended    

 

(in thousands, except percentages)

 

September 29,

2017

  

September 30,

2016

  

Percent

Change

 
          
Other operating expenses $21,966  $21,221   3.5%
Percentage of total revenues  8.5%  8.9%    

Other operating expenses include facilities-related costs, technical materials, computer-related expenses and depreciation and amortization of property, equipment and leasehold improvements. The increase in other operating expenses during the first nine months of 2017 was primarily due to an increase in depreciation expense of $253,000, an increase in occupancy expense of $158,000, and an increase in computer expense of $155,000 associated with investments in our corporate infrastructure.

Reimbursable Expenses      
  Nine Months Ended    

 

(in thousands, except percentages)

 

September 29,

2017

  

September 30,

2016

  

Percent

Change

 
          
Reimbursable expenses $12,571  $11,619   8.2%
Percentage of total revenues  4.8%  4.9%    

The increase in reimbursable expenses was primarily due to an increase in travel related costs associated with our large human factors assessment project. The amount of reimbursable expenses will vary from quarter to quarter depending on the nature of our projects.

- 22 -

General and Administrative Expenses      
  Nine Months Ended    
(in thousands, except percentages) 

September 29,

2017

  

September 30,

2016

  

Percent

Change

 
          
General and administrative expenses $13,277  $11,407   16.4%
Percentage of total revenues  5.1%  4.8%    

The increase in general and administrative expenses during the first nine months of 2017 was primarily due to an increase in travel and meals of $1,010,000, an increase in legal expenses of $246,000, and an increase in marketing and promotion of $141,000. The increase in travel and meals was due to a firm-wide managers’ meeting which occurs every other year. The increase in marketing and promotion was due to several initiatives associated with the firm’s 50th anniversary.

Other Income, Net      
  Nine Months Ended    

 

(in thousands, except percentages)

 

September 29,

2017

  

September 30,

2016

  

Percent

Change

 
          
Other income, net $7,532  $5,369   40.3%
Percentage of total revenues  2.9%  2.3%    

Other income, net, consists primarily of changes in the value of assets associated with our deferred compensation plan, interest income earned on available cash, cash equivalents and short-term investments, and rental income from leasing space in our Silicon Valley facility. During the first nine months of 2017, other income, net, increased $1,794,000 with a corresponding increase to deferred compensation expense, as compared to the same period last year, due to a change in the value of assets associated with our deferred compensation plan. This increase consisted of an increase in the value of the plan assets of $4,617,000 during the first nine months of 2017 as compared to an increase in the value of the plan assets of $2,823,000 during the same period last year. The increase in other income, net, was also due to an increase in interest income of $383,000 due to higher interest rates for our cash equivalents and short-term investments.

Income Taxes      
  Nine Months Ended    
(in thousands, except percentages) 

September 29,

2017

  

September 30,

2016

  

Percent

Change

 
          
Income taxes $16,778  $15,239   10.1%
Percentage of total revenues  6.5%  6.4%    
Effective tax rate  27.2%  29.1%    

The increase in income tax expense was due to a corresponding increase in pre-tax income. The decrease in our effective tax rate was due to an increase in the excess tax benefit associated with share-based awards and a decrease in our unrecognized tax benefit. The excess tax benefit associated with share-based awards increased to $6,518,000 during the first nine months of 2017 as compared to $4,827,000 during the same period last year. During the first nine months of 2017 we released $437,000 of our unrecognized tax benefit due to the completion of two tax audits.

LIQUIDITY AND CAPITAL RESOURCES

 

  Nine Months Ended 

 

(in thousands)

 

September 29,

2017

  

September 30,

2016

 
       
Net cash provided by operating activities $26,964  $37,234 
Net cash used in investing activities  (20,351)  (19,113)
Net cash used in financing activities  (32,637)  (44,816)

- 23 -

We financed our business during the first nine months of 2017 through available cash. We invest our excess cash in cash equivalents and short-term investments. As of September 29, 2017, our cash, cash equivalents and short-term investments were $165.6 million compared to $173.7 million at December 30, 2016. We believe our existing balances of cash, cash equivalents, short-term investments and cash generated from operations will be sufficient to satisfy our working capital needs, capital expenditures, outstanding commitments, stock repurchases, dividends and other liquidity requirements over at least the next twelve months. However, we continue to monitor the impact of the COVID-19 pandemic on our cash flows and on the credit and financial markets.

 

 

 

Three Months Ended

 

(in thousands)

 

April 3,

2020

 

 

March 29,

2019

 

Net cash used in operating activities

 

$

(13,835

)

 

$

(12,253

)

Net cash provided by (used in) investing activities

 

 

7,707

 

 

 

(16,518

)

Net cash used in financing activities

 

 

(64,324

)

 

 

(19,415

)

We financed our business during the first three months of 2020 through available cash. We invest our excess cash in cash equivalents and short-term investments. As of April 3, 2020, our cash, cash equivalents and short-term investments were $152,043,000 as compared to $231,601,000 at January 3, 2020.

Generally, our net cash provided by operating activities is used to fund our day to day operating activities. First quarter operating cash requirements are generally higher due to payment in the first quarter of our annual bonuses accrued during the prior year. Our largest source of operating cash flows is collections from our clients. Our primary uses of cash from operating activities are for employee related expenditures, leased facilities, taxes, and general operating expenses including marketing and travel.

The decreaseincrease in net cash provided by operatinginvesting activities during the first ninethree months of 20172020, as compared to the same period last year, was primarily due to an increasea decrease in accounts receivable.the purchase of short-term investments, net of maturities, and a decrease in capital expenditures. The decrease in capital expenditures was due to the completion of construction of our office and laboratory facilities in Natick, Massachusetts during 2019.

- 25 -


 

The increase in net cash used in investingfinancing activities during the first ninethree months of 2017,2020, as compared to the same period last year, was due to an increase in the purchase of short-term investments, net of maturities partially offset by a decrease in capital expenditures.

The decrease in net cash used in financing activities during the first nine months of 2017, as compared to the same period last year, was due to a decrease in repurchases of our common stock, partially offset by an increase in payroll taxes for restricted stock units and an increase in dividend payments.

We expect to continue our investing activities, including capital expenditures. Furthermore, cash reserves may be used to repurchase shares of common stock under our stock repurchase programs, pay dividends, or strategically acquire professional service firms that are complementary to our business.

For a summary of our commitments to make future payments under contractual obligations, see “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources” in our 20162019 Annual Report.

During April 2017, we entered into two agreements to purchase a total of 2.9 acres of land in Natick, Massachusetts on which we intend to build office and laboratory facilities. The total purchase price is $5,200,000. The purchase agreements are contingent on several items including feasibility studies, environmental assessments, and government approvals. If we determine that the property is unsuitable for the planned project, we can terminate the agreements to purchase the land at our sole discretion.

There have been no other material changes in our contractual obligations since December 30, 2016.

January 3, 2020.

We maintain a nonqualified deferred compensation plan for the benefit of a select group of highly compensated employees. Vested amounts due under the plan of $50,778,000$64,026,000 were recorded as a long-term liability on our unaudited condensed consolidated balance sheet at September 29, 2017.April 3, 2020. Vested amounts due under the plan of $5,839,000 were recorded as a current liability on our unaudited condensed consolidated balance sheet at April 3, 2020. Company assets that are earmarked to pay benefits under the plan are held in a rabbi trust and are subject to the claims of our creditors. As of September 29, 2017,April 3, 2020, invested amounts under the plan of $46,678,000$63,353,000 were recorded as a long-term asset on our unaudited condensed consolidated balance sheet.

As of April 3, 2020, invested amounts under the plan of $5,489,000 were recorded as a current asset on our unaudited condensed consolidated balance sheet.

As permitted under Delaware law, we have agreements whereby we indemnify our officers and directors for certain events or occurrences while the officer or director is, or was, serving at our request in such capacity. The indemnification period covers all pertinent events and occurrences during the officer’s or director’s lifetime. The maximum potential amount of future payments we could be required to make under these indemnification agreements is unlimited; however, we have director and officer insurance coverage that reduces our exposure and enables us to recover a portion of any future amounts paid.

- 24 -

Non-GAAP Financial Measures

Regulation G, Conditions for Use of Non-Generally Accepted Accounting Principles ("Non-GAAP") Financial Measures, and other SECU.S. Securities and Exchange Commission (“SEC”) rules and regulations define and prescribe the conditions for use of Non-GAAP financial information. Generally, a Non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. We closely monitor two financial measures, EBITDA and EBITDAS, which meet the definition of Non-GAAP financial measures. We define EBITDA as net income before income taxes, net interest income, depreciation and amortization. We define EBITDAS as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. These measures are used to evaluate our financial results, develop budgets and determine employee compensation. These measures, however, should be considered in addition to, and not as a substitute for or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the Non-GAAP measures to the nearest comparable GAAP measure is set forth below.

The following table shows EBITDA (determined as shown in the reconciliation table below) as a percentage of revenues before reimbursements for the three and nine months ended SeptemberApril 3, 2020 and March 29, 2017 and September 30, 2016:2019:

 

 Three Months Ended  Nine Months Ended 

 

Three Months Ended

 

(in thousands, except percentages)

 

September 29,

2017

 

September 30,

2016

 

September 29,

2017

 

September 30,

2016

 

 

April 3,

2020

 

 

March 29,

2019

 

         
Revenues before reimbursements $82,359  $74,160  $246,946  $226,444 

 

$

99,720

 

 

$

93,401

 

                
EBITDA $23,225  $19,323  $65,678  $56,351 

 

$

24,966

 

 

$

23,857

 

                
EBITDA as a % of revenues before reimbursements  28.2%  26.1%  26.6%  24.9%

 

 

25.0

%

 

 

25.5

%

- 26 -


 

The increasedecrease in EBITDA as a percentage of revenues before reimbursements during the thirdfirst quarter of 20172020 as compared to the same period last year was primarily due to anthe increase in utilization. Utilizationgeneral and administrative expenses associated with the additional reserves we booked to our allowance for the third quarter of 2017 was 76% as compared to 70% during the same period last year.

The increase in EBITDAdoubtful accounts as a percentageresult of revenues before reimbursements during the first nine months of 2017 as compared toeconomic uncertainty associated with the same period last year was primarily due to an increase in utilization. Utilization for the first nine months of 2017 was 76% as compared to 71% during the same period last year.COVID-19 pandemic

- 25 -

 

The following table is a reconciliation of EBITDA and EBITDAS to the most comparable GAAP measure, net income, for the three and nine months ended September 29, 2017 and September 30, 2016:April 3, 2020:

 

  Three Months Ended  Nine Months Ended 

 

(in thousands)

 

September 29,

2017

  

September 30,

2016

  

September 29,

2017

  

September 30,

2016

 
             
Net income $14,643  $11,289  $45,010  $37,092 
                 
Add back (subtract):                
                 
Income taxes  7,387   6,631   16,778   15,239 
Interest income, net  (372)  (179)  (872)  (489)
Depreciation and amortization  1,567   1,582   4,762   4,509 
                 
EBITDA  23,225   19,323   65,678   56,351 
                 
Stock-based compensation  3,541   2,730   12,728   10,659 
                 
EBITDAS $26,766  $22,053  $78,406  $67,010 

 

 

Three Months Ended

 

(in thousands)

 

April 3,

2020

 

 

March 29,

2019

 

Net income

 

$

26,282

 

 

$

22,712

 

Add back (subtract):

 

 

 

 

 

 

 

 

Income taxes

 

 

(2,227

)

 

 

610

 

Interest income, net

 

 

(875

)

 

 

(1,055

)

Depreciation and amortization

 

 

1,786

 

 

 

1,590

 

EBITDA

 

 

24,966

 

 

 

23,857

 

Stock-based compensation

 

 

6,138

 

 

 

5,731

 

EBITDAS

 

$

31,104

 

 

$

29,588

 

Item 3.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to interest rate risk associated with our balances of cash, cash equivalents and short-term investments. We manage our interest rate risk by maintaining an investment portfolio primarily consisting of debt instruments with high credit quality and relatively short average effective maturities in accordance with our investment policy. The maximum effective maturity of any issue in our portfolio is 3 years and the maximum average effective maturity of the portfolio cannot exceed 12 months. If interest rates were to instantaneously increase or decrease by 100 basis points, the change in the fair market value of our portfolio of cash equivalents and short-term investments would not have a material impact on our financial statements. We do not use derivative financial instruments in our portfolio. There have not been any material changes during the period covered by this Quarterly Report on Form 10-Q to our interest rate risk exposures, or how these exposures are managed. Notwithstanding our efforts to manage interest rate risk, there can be no assurances that we will be adequately protected against the risks associated with interest rate fluctuations.

We have foreign currency risk related to our revenues and expenses denominated in currencies other than the U.S. dollar, primarily the British Pound, the Euro, the Chinese Yuan, and the Chinese Yuan.Hong Kong Dollar. Accordingly, changes in exchange rates may negatively affect the revenues and net income of our foreign subsidiaries as expressed in U.S. dollars.

At September 29, 2017,April 3, 2020, we had net assets of approximately $10.0$6.9 million with a functional currency of the British Pound, net assets of approximately $4.1$1.5 million with a functional currency of the Euro, and net assets of approximately $4.0$5.5 million with a functional currency of the Chinese Yuan, and net assets of approximately $3.8 million with a functional currency of the Hong Kong Dollar associated with our operations in the United Kingdom, Germany, China, and China,Hong Kong respectively.

We also have foreign currency risk related to foreign currency transactions and monetary assets and liabilities denominated in currencies that are not the functional currency. We have experienced and will continue to experience fluctuations in our net income as a result of gains (losses) on these foreign currency transactions and the remeasurement of monetary assets and liabilities. At September 29, 2017,April 3, 2020, we had net assets denominated in the non-functional currency of approximately $2.6$0.7 million. As such, a ten percent change in the value of the local currency would result in a $260,000 foreign currency gain or loss in our results of operations.

- 27 -


 

We do not use foreign exchange contracts to hedge any foreign currency exposures. To date, the impacts of foreign currency exchange rate changes on our consolidated revenues and consolidated net income have not been material.significant. However, our continued international growth increases our exposure to exchange rate fluctuations and as a result such fluctuations could have a significant impact on our future results of operations.

- 26 -

Item 4. Controls and Procedures

Item 4.Controls and Procedures

 

(a)

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended, an evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) of the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this quarterly report. Based on that evaluation, the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, concluded that, as of September 29, 2017,April 3, 2020, the Company’s disclosure controls and procedures were effective.

We intend to review and evaluate the design and effectiveness of our disclosure controls and procedures on an ongoing basis, to improve our controls and procedures over time and to correct any deficiencies that we may discover in the future. Our goal is to ensure that our senior management has timely access to all material financial and non-financial information concerning our business. While we believe the present design of our disclosure controls and procedures is effective to achieve our goal, future events affecting our business may cause us to significantly modify our disclosure controls and procedures.

 

(b)

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the three monththree-month period ended September 29, 2017April 3, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We have not experienced any material impact to our internal controls over financial reporting despite the fact that most of our employees are working remotely due to the COVID-19 pandemic.

- 28 -


 

PART II - OTHER INFORMATION

Item 1.

Exponent is not engaged in any material legal proceedings.

Item 1A. Risk Factors

Item 1A. Risk Factors

Exponent operates in a rapidly changing environment that involves a number of uncertainties, some of which are beyond our control and may have a material adverse effect on our financial condition and results of operations. These uncertainties include, but are not limited to, those mentioned elsewhere in this report and those set forth below.

 

ThereThe effects of the COVID-19 pandemic have materially affected our operations and those of our clients. The duration and extent to which this will impact our future financial condition and results of operations remains uncertain.

In March 2020, the World Health Organization declared the outbreak of COVID-19 a pandemic, which continues to spread throughout the U.S. and the world and has resulted in authorities implementing numerous measures to contain the virus, including travel bans and restrictions, quarantines, shelter-in-place orders, and business limitations and shutdowns. While we are unable to accurately predict the full impact that COVID-19 will have on our financial condition and results of operations due to numerous uncertainties, including the duration and severity of the pandemic and containment measures, compliance with these measures has impacted our operations.

The vast majority of our employees have been working remotely since the implementation of government measures to contain the virus. These remote working arrangements may result in inefficiencies, delays and additional costs and risks. In addition, most of our clients are also working remotely, which may delay the initiation of new projects and the execution of on-going work. We have seen slowing of a portion of our litigation support projects due to courthouse closures and associated legal delays. Travel restrictions are delaying work that requires inspection of a site or a product that cannot be shipped. The pandemic has also temporarily paused our user studies.

The COVID-19 pandemic also raises the possibility of an extended global economic downturn and has caused volatility in financial markets, which could affect demand for our services and impact our financial condition and results of operations even after the pandemic is contained and the containment measures are lifted. For example, we may be unable to collect receivables from those customers significantly impacted by COVID-19. We believe that our existing balances of cash, cash equivalents, short-term investments and cash generated from operations to be sufficient to satisfy our working capital needs, capital expenditures, outstanding commitments, stock repurchases, dividends and other liquidity requirements over at least the next twelve months. However, we continue to monitor the impact of the COVID-19 pandemic on our cash flows and on the credit and financial markets.

The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the severity and transmission rate of the virus, the extent and effectiveness of containment actions, and the impact of these and other factors on our employees and clients. We will continue to evaluate the nature and extent of the impact of the COVID-19 pandemic to our business.

The unpredictable and reactive nature of our business can create uneven performance in any given quarter or fiscal year.

Revenues are primarily derived from services provided in response to client requests or events that occur without notice, and engagements, generally billed as services are performed, are terminable or subject to postponement or delay at any time by clients. As a result, backlog at any particular time is small in relation to our quarterly or annual revenues and is not a reliable indicator of revenues for any future periods. Revenues and operating margins for any particular quarter are generally affected by staffing mix, resource requirements and timing and size of engagements.

- 29 -


Our financial results could suffer if our clients’ needs change more rapidly than we are able to secure the appropriate mix of trained, skilled and experienced personnel.

As our clients’ needs change, new technologies develop, and legal and regulatory processes change, we may be unable to timely hire or train personnel with the appropriate new set of skills and experience which could negatively impact our growth and profitability.

Failure to attract and retain key employees may adversely affect our business.

Exponent’s business involves the delivery of professional services and is labor-intensive. Our success depends in large part upon our ability to attract, retain and motivate highly qualified technical and managerial personnel. Qualified personnel are in great demand and are likely to remain a limited resource for the foreseeable future. We cannot provide any assurance that we can continue to attract sufficient numbers of highly qualified technical and managerial personnel and retain existing employees. We have experienced and expect to continue to experience employee turnover. The loss of key managerial employees, business generators or any significant number of employees could have a material adverse impact on our business, including our ability to secure and complete engagements.

Competition could reduce our pricing and adversely affect our business.

The markets for our services are highly competitive. In addition, there are relatively low barriers to entry into our markets and we have faced, and expect to continue to face, additional competition from new entrants into our markets. Competitive pressure could reduce the market acceptance of our services and result in price reductions that could have a material adverse effect on our business, financial condition or results of operations.

The loss of a large client could adversely affect our business.

We currently derive a significant portion of our revenues from clients in the chemical, construction, consumer products, energy, life sciences, and transportation industries. The loss of any large client could have a material adverse effect on our business, financial condition or results of operations.

Our clients may be unable to pay for our services.

If a client's financial difficulties become severe, the client may be unwilling or unable to pay our invoices in the ordinary course of business, which could adversely affect collections of both our accounts receivable and unbilled services. The COVID-19 pandemic raises the possibility of an extended global economic downturn which may impact the ability of our customers to pay for our services. On occasion, some of our clients have entered bankruptcy, which has prevented us from collecting amounts owed to us. The bankruptcy of a client with substantial accounts receivable could have a material adverse effect on our financial condition and results of operations.

On January 29, 2019, PG&E Corp. (“PG&E”) filed for bankruptcy under chapter 11 of the U.S. bankruptcy code. As of April 3, 2020, our total pre-bankruptcy outstanding accounts receivable from PG&E was $3.0 million. We currently expect to collect substantially all of the pre-bankruptcy accounts receivable from PG&E. However, due to the risks and uncertainties inherent in the bankruptcy process, the amount ultimately collected could differ from our current expectation. We continue to do work for PG&E post-bankruptcy filing and expect to be paid for this work in the ordinary course of business. Under the United States Bankruptcy code, PG&E is required to pay all post-bankruptcy expenses in the normal course of business. If they do not do so, we are eligible to have the post-bankruptcy obligation categorized as an administrative expense entitled to priority over most pre-bankruptcy creditors.

We hold substantial investments that could present liquidity risks.

Our cash equivalent and short-term investment portfolio as of April 3, 2020, consisted primarily of obligations of the U.S. Treasury. We follow an established investment policy to monitor, manage and limit our exposure to interest rate and credit risk. The policy sets forth credit quality standards and limits our exposure to any one issuer, as well as our maximum exposure to various asset classes.

- 30 -


Investments in some financial instruments may pose risks arising from liquidity and credit concerns. As of April 3, 2020, we had no impairment charge associated with our investment portfolio relating to such adverse financial market conditions. Although we believe our current investment portfolio has a low risk of impairment, we cannot predict future market conditions or market liquidity and can provide no assurance that our investment portfolio will remain unimpaired.

Our business is dependent on our professional reputation.

The professional reputation of Exponent and its consultants is critical to our ability to successfully compete for new client engagements and attract or retain professionals. Proven or unproven allegations against us may damage our professional reputation. Any factors that damage our professional reputation could have a material adverse effect on our business.

Our business can be adversely impacted by deregulation or reduced regulatory enforcement.

Public concern over health, safety and preservation of the environment has resulted in the enactment of a broad range of environmental and/or other laws and regulations by local, state and federal lawmakers and agencies. These laws and the implementation of new regulations affect nearly every industry, as well as the agencies of federal, state and local governments charged with their enforcement. To the extent changes in such laws, regulations and enforcement or other factors significantly reduce the exposures of manufacturers, owners, service providers and others to liability, the demand for our services may be significantly reduced.

Tort reform can reduce demand for our services.

Several of our practices have a significant concentration in litigation support consulting services. To the extent tort reform reduces the exposure of manufacturers, owners, service providers and others to liability, the demand for our litigation support consulting services may be significantly reduced.

Our engagements may result in professional or other liability.

Our services typically involve difficult engineering and scientific assignments and carry risks of professional and other liability. Many of our engagements involve matters that could have a severe impact on a client's business, cause a client to lose significant amounts of money, or prevent a client from pursuing desirable business opportunities. Accordingly, if a client is dissatisfied with our performance, the client could threaten or bring litigation in order to recover damages or to contest its obligation to pay our fees. Litigation alleging that we performed negligently, disclosed client confidential information, lost or damaged evidence, infringed on patents, were forced to withdraw from a legal matter due to a conflict or otherwise breached our obligations to a client could expose us to significant liabilities to our clients or other third parties or tarnish our reputation.

Potential conflicts of interest may preclude us from accepting some engagements.

We provide litigation support consulting and other services primarily in connection with significant disputes, or other matters that are usually adversarial or that involve sensitive client information. The nature of our consulting services has and will continue to preclude us from accepting engagements with other potential clients because of conflicts. Accordingly, the nature of our business limits the number of both potential clients and potential engagements.

We are subject to unpredictable risks of litigation.

Although we seek to avoid litigation whenever possible, from time to time we are party to various lawsuits and claims. Disputes may arise, for example, from employment issues, regulatory actions, business acquisitions and real estate and other commercial transactions. There can be no assurances that any lawsuits or claims will be immaterial in the future. Any material lawsuits or claims could adversely affect our business and reputation.

- 31 -


We are subject to security breaches that may disrupt our operations and/or lead to the inability to protect confidential information.

We have experienced, and expect to continue to be subjected to, security breaches and threats, none of which have been material to us to date. Despite the implementation of security measures, our operating systems are vulnerable to electronic breaches of security. Such breaches could lead to disruptions of our operations and potential unauthorized disclosure of confidential and/or personal information, which could result in legal claims or proceedings. While we have taken reasonable steps to prevent and mitigate the damage of a security breach by continuously improving our design and coordination of security controls across our business, those steps may not be effective and there can be no assurance that any such steps can be effective against all possible risks.

Failure to protect client and employee data may have an adverse effect on our business.

We manage, utilize, and store sensitive or confidential client or employee data, including personal data and protected health information. As a result, we are subject to numerous laws and regulations designed to protect this information, such as the U.S. federal and state laws governing the protection of health or other personally identifiable information, including the Health Insurance Portability and Accountability Act, and international laws such as the European Union General Data Protection Regulation. In addition, many states, U.S. federal governmental authorities and non-U.S. jurisdictions have adopted, proposed, or are considering adopting or proposing, additional data security and/or data privacy statutes or regulations. These laws and regulations are increasing in complexity and number. If any person, including any of our employees, negligently disregards or intentionally breaches our established controls with respect to client or employee data, or otherwise mismanages or misappropriates that data, we could be subject to significant monetary damages, regulatory enforcement actions, fines, and/or criminal prosecution. In addition, unauthorized disclosure of sensitive or confidential client or employee data, whether through systems failure, employee negligence, fraud, or misappropriation, could damage our reputation and cause us to lose clients and their related revenue in the future. Our remote working arrangements due to the COVID-19 pandemic may increase the risks associated with protecting client and employee data.

Impairment of goodwill may require us to record a significant charge to earnings.

On our balance sheet, we have $8,607,000 of goodwill subject to periodic evaluation for impairment. Failure to achieve sufficient levels of cash flow at reporting units, the loss of key employees, changes to the scope of operations of our business or a significant and sustained decline in our stock price could result in goodwill impairment charges. The COVID-19 pandemic raises the possibility of an extended global economic downturn which increase the risk of goodwill impairment charges. During times of financial market volatility, significant judgment is required to determine the underlying cause of the decline and whether stock price declines are short-term in nature or indicative of an event or change in circumstances.

Impairment of long-lived assets or restructuring activities may require us to record a significant charge to earnings.

Our long-lived assets, including our office, laboratory and warehouse space in Menlo Park, California, our test and engineering center in Phoenix, Arizona, and our office and laboratory facilities in Natick, Massachusetts, are subject to periodic testing for impairment. Failure to achieve sufficient levels of cash flow at the asset group level could result in impairment of our long-lived assets. In addition, we have operating lease right-of-use assets for office and laboratory space. Changes in the business environment could lead to changes in the scope of operations of our business. These changes, including the closure of one or more offices, could result in restructuring and/or asset impairment charges. The COVID-19 pandemic raises the possibility of an extended global economic downturn which increase the risk of long-lived asset impairment charges

Our international operations create special risks that could adversely affect our business.

In addition to our offices in the United States, we have physical offices in the United Kingdom, Germany, Switzerland, Hong Kong, China, Singapore, Ireland, and Canada, and conduct business in several other countries. We expect to continue to expand globally and our international revenues may account for an increasing portion of our revenues in the future. Our international operations carry special financial, business and legal risks, including cultural and language differences; employment laws and related factors that could result in lower utilization, higher

- 32 -


staffing costs, and cyclical fluctuations of utilization and revenues; currency fluctuations that adversely affect our financial position and operating results; burdensome regulatory requirements and other barriers to conducting business; tariffs and other trade barriers including the United Kingdom’s decision to leave the European Union; managing the risks associated with engagements with foreign officials and governmental agencies, including the risks arising from the United States Foreign Corrupt Practices Act and the United Kingdom Bribery Act of 2010; managing the risks associated with global privacy and data security laws and regulations including the General Data Protection Regulation in Europe; greater difficulties in managing and staffing foreign operations; successful entry and execution in new markets; restrictions on the repatriation of earnings; potentially adverse tax consequences; and other impending legislation that could add additional risks to the business.

Inherent risks related to government contracts may adversely affect our business.

We work for various United States and foreign governmental entities and agencies. Government entities reserve the right to audit our contracts and conduct inquiries and investigations of our business practices with respect to government contracts. Findings from an audit may result in fees being refunded to the government or prospective adjustment to previously agreed upon rates that will affect future margins. If a government client discovers improper or illegal activities in the course of audits or investigations, we may become subject to various civil and criminal penalties and administrative sanctions, which may include termination of contracts, forfeiture of profits, suspension of payments, fines and suspensions or debarment from doing business with other agencies of the government. The inherent limitations of internal controls may not prevent or detect all improper or illegal activities, regardless of the adequacy of such controls. Government contracts, and the proceedings surrounding them, are often subject to more extensive scrutiny and publicity than other commercial contracts. Negative publicity related to our government contracts, regardless of whether it is accurate, may further damage our business by affecting our ability to compete for new contracts.

Governments may terminate, cancel, modify or curtail our contracts at any time prior to their completion.

Under our government contracts, the client generally has the right not to exercise options to extend or expand our contracts and may otherwise terminate, cancel, modify or curtail our contracts at its convenience. Any decision by the client not to exercise contract options or to terminate, cancel, modify or curtail our programs or contracts would adversely affect our revenues, revenue growth and profitability.

We could incur significant liabilities and suffer negative publicity if people or properties are harmed by the products and systems we sell or the services we offer.

We, on occasion, design, develop, manufacture, sell, service and maintain various products and systems. In some instances, we also train operators of such products and systems. Many of these products and systems utilize software algorithms that are probabilistic in nature and subject to significant technical limitations. There are many factors, some of which are beyond our control, which could result in the failure of our products or systems. The failure of our products or systems could lead to injury, death, or extensive property damage and may lead to product liability, professional liability, or other claims against us. Further, if our products or systems fail, or are perceived to have failed, the negative publicity from such incident could have a material adverse effect on our business.

Changes in, or interpretations of, accounting principles could have a significant impact on our financial position and results of operations.

We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (“GAAP”). These principles are subject to interpretation by the SEC and various bodies formed to interpret and create appropriate accounting principles. A change in these principles can have a significant effect on our reported results and may even retroactively affect previously reported transactions. Additionally, the adoption of new or revised accounting principles may require that we make significant changes to our systems, processes and controls.

Our business can be adversely affected by downturns in the overall economy.

The markets that we serve are cyclical and subject to general economic conditions. The direction and relative strength of the global economy continues to be uncertain. If economic activity in the United States, where

- 33 -


we primarily operate, continues to decline, our clients may consolidate or go out of business and thus demand for our services could be reduced significantly.

Our quarterly results may vary.

Variations in our revenues and operating results occur from time to time, as a result of a number of factors, such as the significance of client engagements commenced and completed during a quarter, the timing of engagements, the number of working days in a quarter, employee hiring and utilization rates, and integration of companies acquired. Because a high percentage of our expenses, particularly personnel and facilities related expenses, are relatively fixed in advance of any particular quarter, a variation in the timing of the initiation or the completion of our client assignments can cause significant variations in operating results from quarter to quarter.

The market price of our common stock may be volatile.

Many factors could cause the market price of our common stock to rise and fall. These include the risk factors as previously discussed under the heading “Risk Factors”listed above and below; changes in estimates of our performance or recommendations by securities analysts; future sales of shares of common stock in the Company’s 2016 Annual Report.public market; market conditions in the industry and economy as a whole; acquisitions or strategic alliances involving us or our competitors; restatement of financial results; and changes in accounting principles or methods. In addition, the stock market often experiences significant price fluctuations. These fluctuations are often unrelated to the operating performance of particular companies. These broad market fluctuations may adversely affect the market price of our common stock. When the market price of a company's stock drops significantly, shareholders often institute securities class action litigation against that company. Any litigation against us could cause us to incur substantial costs, divert the time and attention of our management and other resources, or otherwise harm our business.

There can be no assurance that we will continue to declare cash dividends or repurchase our shares at all or in any particular amounts.

Our Board of Directors has declared quarterly dividends since March 2013. Our intent to continue to pay quarterly dividends and to repurchase our shares is subject to capital availability and, in the case of dividends, periodic determinations by our Board of Directors that cash dividends are in the best interest of our stockholders and are in compliance with all laws and agreements applicable to the declaration and payment of cash dividends by us. Future dividends and share repurchases may also be affected by, among other factors: our views on potential future capital requirements for investments, including acquisitions; legal risks; stock repurchase programs; changes in federal and state income tax laws or corporate laws; contractual restrictions; and changes to our business model. Our dividend payments and share repurchases may change from time to time, and we cannot provide assurance that we will continue to declare dividends or repurchase shares at all or in any particular amounts. A reduction or suspension in our dividend payments or share repurchase activity could have a negative effect on our stock price.

Catastrophic events may disrupt our business.

We rely on our network infrastructure and certain third-party hosted services to support our operations. A disruption or failure of these systems in the event of a major earthquake, fire, flood, tsunami or other weather event, power loss, telecommunications failure, software or hardware malfunctions, pandemics, or epidemics where we have operations, cyber-attack, war, terrorist attack or other catastrophic event that our disaster recovery plans do not adequately address, could have a material adverse effect on our business, financial condition or results of operations.

 

Climate change may have a long-term impact on our business.

The areas where we conduct business are vulnerable to the effects of climate change. For example, in California, wildfire danger increases the probability of planned power outages which may impact our employees’ abilities to commute to work and to stay connected. Climate-related events, including the increasing frequency of extreme weather events and their impact on critical infrastructure, have the potential to disrupt our business.

- 34 -


Item 2.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information on the Company’s repurchases of the Company’s common stock for the three months ended September 29, 2017April 3, 2020 (in thousands, except price per share):

 

  Total Number
of Shares
Purchased
  Average Price
Paid Per
Share
  Total Number of
Shares Purchased as
Part of Publicly
Announced Programs
  Approximate Dollar
Value of Shares That
May Yet Be
Purchased Under the
Programs(1)
 
             
July 1 to July 28  -  $-   -  $50,303 
July 29 to August 25  -   -   -  $50,303 
August 26 to September 29  22   66.06   22  $48,876 
Total  22  $66.06   22  $48,876 

 

 

Total

Number

of Shares

Purchased

 

 

Average

Price

Paid Per

Share

 

 

Total

Number of

Shares

Purchased

as Part of

Publicly

Announced

Programs

 

 

Approximate

Dollar Value

of Shares That

May Yet Be

Purchased

Under the

Programs (1)

 

January 4 to January 31

 

 

-

 

 

$

-

 

 

 

-

 

 

$

70,504

 

February 1 to February 28

 

 

-

 

 

 

-

 

 

 

-

 

 

 

70,504

 

February 29 to April 3

 

 

636

 

 

 

62.97

 

 

 

636

 

 

 

30,455

 

Total

 

 

636

 

 

$

62.97

 

 

 

636

 

 

$

30,455

 

 

(1)

On October 21, 2015,19, 2016, the Company’s Board of Directors authorizedapproved $35,000,000 for the repurchase of the Company’s common stock. On October 19, 2016,January 31, 2019, the Company’s Board of Directors authorized an additional $35,000,000approved $75,000,000 for the repurchase of the Company’s common stock. These plansrepurchase programs have no expiration date.

- 27 -

Item 3.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5.

Item 5. Other Information

Not applicable.

- 35 -


Item 6. Exhibits

(a)

Item 6.Exhibits

Exhibit Index

 

  31.1

(a)Exhibit Index

31.1Certification of Chief Executive Officer pursuant to Rule 13a – 14(a) under the Securities Exchange Act of 1934.

  31.2

31.2

Certification of Chief Financial Officer pursuant to Rule 13a – 14(a) under the Securities Exchange Act of 1934.

  32.1

32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350.

  32.2

32.2

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350.

101.INS

101.INS

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

Exhibit 104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

- 28 -

 

SIGNATURES- 36 -


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

EXPONENT, INC.

(Registrant)

Date: November 3, 2017May 8, 2020

/s/ Paul R. JohnstonCatherine Ford Corrigan

Paul R. Johnston,

Catherine Ford Corrigan, Ph.D., Chief Executive Officer

/s/ Richard L. Schlenker

Richard L. Schlenker, Chief Financial Officer

- 29 -

 

- 37 -